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ABSTRACT
Infertility is a frequently occurring chronic health condition, which often persists
throughout the reproductive years. Heightened anxiety symptoms often are comorbid
with infertility diagnoses. Women experiencing infertility, and particularly those with
anxiety symptoms, characterize an emerging population that deserves special attention.
However, women experiencing infertility have identified barriers to seeking
psychotherapy (e.g., fears of being dismissed from fertility treatment and/or stigmatized).
Consequently, women diagnosed with infertility need a psychotherapy that not only can
reduce these symptoms, but can also be private and convenient. The current study
translated an empirically tested in-person mind/body protocol into an internet-based
intervention to suit the needs of this population. Seventy-one women were randomly
assigned to the intervention or a wait-list control. At the close of the study, only three
participants had completed the intervention. At mid-assessment, relative to the wait-list
group, the intervention group had a lower level of depressive symptoms and, for those
with elevated anxiety symptoms at baseline, a lower level of anxiety symptoms. The
findings suggest that even a partially completed internet-based intervention can reduce
the anxiety and depressive symptoms of women with a diagnosis of infertility.
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INTRODUCTION

Chronic Health Conditions
It is not uncommon for individuals who suffer from a chronic illness to have a comorbid diagnosis of anxiety and/or depression. Chronic health conditions are typically
defined as diseases of long duration and generally slow progression (“Noncommunicable
Diseases,” 2013). Examples of chronic health conditions include arthritis, cancer,
cardiovascular disease (e.g., heart disease and stroke), communicable diseases (e.g.,
human immune deficiency virus), diabetes, obesity, osteoporosis, pulmonary diseases
(e.g., asthma and chronic obstructive pulmonary disease), and infertility.
Prevalence rates of anxiety and depression vary depending on the study and health
condition. However, it appears anxiety occurs in individuals with chronic health
conditions at rates that far exceed those found in the general population (Clarke & Currie,
2009). In fact, a prevalence study of over 200,000 individuals reported that individuals
with cardiovascular disease had a 2.2-fold and those with diabetes had an 1.6-fold
likelihood of having a co-morbid anxiety disorder (Strine et al., 2008). Results from a
longitudinal study indicated that individuals with a general “chronic medical disorder”
were more likely to have a persistent anxiety or mood disorders at baseline and follow-up
(follow-up ranged from 2 to 3 years; A. Young, Klap, Shoai, & Wells, 2008).
Although some research has pointed to anxiety as a risk factor for the onset of
chronic health conditions, such as diabetes and cancer, it is clear that the chronic health
1

conditions act in combination with ancillary aspects such as unrelieved pain, functional
impairment, social isolation, and invasive treatment regimens as risk factors for the
development and/or maintenance of anxiety, which, in turn, can exacerbate disease
severity (Clarke & Currie, 2009). In individuals diagnosed with chronic illness, anxiety
symptoms are often comorbid with depressive symptoms (Clarke & Currie, 2009).
Furthermore, co-morbid depression is associated with non-compliance with medical
treatment, greater medical complications, longer hospital stays, and increased morbidity
and mortality (Clarke & Currie, 2009).
Infertility is a chronic health condition associated with comorbid anxiety that has
received less attention in the field of clinical psychology as compared to other chronic
health conditions, such as cancer (Domar, Zuttermeister, & Friedman, 1993). However,
women who experience comorbid infertility and heightened anxiety symptoms are a
particularly high-risk group for several reasons, including the fact that the anxiety
symptoms (especially pregnancy-specific anxiety) tend to outlast the infertility diagnosis
(for a review see Gourounti, 2015), the risk for exacerbation of these symptoms due to
fertility treatment and/or pregnancy (e.g., Austin, Tully & Parker, 2007; Gourounti et al.,
2010), and the potential long-term negative effect these symptoms can have on an infant
(e.g., Beijers, Jansen, Riksen-Walraven, & de Weerth, 2010).

Infertility
Infertility (sometimes referred to as subfertility; Kuohung & Hornstein, 2016) has
been defined as the inability to conceive after twelve months of having regular,
2

unprotected intercourse (e.g., ASRM, 2012; CDC, 2013; WHO, 2013). Alternatively,
women 35 years of age or older are considered infertile after failing to conceive after six
months of having regular, unprotected intercourse (ASRM, 2012). The World Health
Organization (2013) extends the medical definition of infertility to include both those
who are unable to conceive as well as those who are unable to maintain a pregnancy
and/or carry the pregnancy to a live birth. Infertility has been described as a “unique
medical condition because it involves a couple, rather than an individual” (Kuohung &
Hornstein, 2016, para. 3). Although infertility is often seen as a heterosexual “couples”
issue, infertility also affects single individuals and same-sex couples. Most professional
medical organizations (e.g., ASRM, WHO, CDC) exclude some single individuals and
same-sex couples from meeting criteria for infertility by including the term “regular
[timed] unprotected sexual intercourse/sex.” Interestingly, potentially based on social and
political pressure to include coverage of reproductive care to these individuals/couples,
insurance agencies appear to be expanding the definition: “For women without male
partners or exposure to sperm, infertility is the inability to conceive after 6 cycles of
Artificial Insemination or Intrauterine Insemination” (Harvard Pilgrim Health Care, Inc,
2015, para. 3). Similar to other chronic health conditions, co-morbid anxiety symptoms
are common in infertile women. Additionally, the severity of anxiety symptoms are
equivalent to that observed in individuals with other chronic health conditions, such as
cancer, cardiac rehabilitation, high blood pressure, and a positive HIV status (Domar,
Zuttermeister, & Friedman, 1993).

3

Infertility prevalence rates. Utilizing the definition provided by the CDC (2013),
the prevalence rates for infertility is about 16%. However, there is a wide variation in
prevalence estimates, which may be explained by differences in the definitions used to
assess condition (i.e., never conceived versus never given birth), the time spam utilized
for the assessment (i.e., lifetime vs. current diagnosis), the inclusion of different age
ranges (i.e., ages 15 to 49), and/or country of origin (i.e., developed versus not
developed). For example, while for some studies infertility may be defined as the
inability to produce offspring (i.e., sterility), in others it is conceptualized as the inability
to conceive within a certain period of time (i.e., 6 to 12 months). One review article
found that the prevalence ranged between 3.3% to 26.4% for current infertility diagnoses
and between 2.6% and 31.8% for lifetime infertility diagnosis (Gurunath, Pandian,
Anderson, & Bhattacharya, 2011). Another review article reported a similar, yet
narrower, range for infertility prevalence rates, ranging between 3.5% to 16.7% for
current infertility diagnosis (within a 12-month duration) and 6.6% to 26.4% for lifetime
infertility diagnosis (Boivin, Bunting, Collins, & Nygren, 2007). These authors
concluded that the median estimate for a current infertility diagnosis among women was
9%, which estimates that approximately 72.4 million women worldwide aged 20-44 have
a current infertility diagnosis. In the United States (USA), specifically, 15.5% (95%
Confidence Intervals: 12.4% to 27.5%) of couples have been estimated to meet criteria
for a current infertility diagnosis (Thoma et al., 2013). There are over 63 million
heterosexual couples living together in the USA today (Lofquist, Lugaila, O’Connell, &
Feliz, 2012) and over half of these couples are probably of reproductive age (Howden &
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Meyer, 2011); therefore, we can estimate that 4 to 9 million couples in the USA today
meet criteria for an infertility diagnosis.

Statement of the Problem
As many as 31.8% of women are estimated to suffer from infertility (Gurunath et
al., 2011). Nearly a quarter of these women are also experiencing heightened anxiety
(Chen, Chang, Tsai, & Juang, 2004). Anxiety disorders, which can be characterized as
emotional disorders, are prevalent and debilitating psychological disorders that
disproportionally affect women (e.g., CDC, 2011) of childbearing age (e.g., Matthey,
2004; Moffitt et al., 2007; Pigott, 2003). Studies estimate that more than 500,000
pregnancies in the United States involve women with psychiatric illnesses that emerged
either before or during pregnancy (“ACOG Practice Bulletin,” 2008). Women diagnosed
with infertility experiencing anxiety symptoms are a special population that deserve
specific attention because they are at increased risk of: (1) developing chronic emotional
disorders; (2) exacerbation of emotional symptoms; and (3) detrimental long-term
outcomes.
Chronic emotional disorders. Infertility puts women at high risk for developing
chronic emotional disorders. Based on the diathesis-stress model (Ingram & Luxton,
2005; Stanton & Dunkel-Schetter, 1991), a major life stressor, such as infertility, which
affects the individual on personal, relational, and social levels (Peterson, Gold, &
Feingold, 2007), can increase the risk for developing an emotional disorder even in
women with mild vulnerabilities (Verhaak et al., 2005). Indeed, infertile individuals have
5

higher rates of anxiety and mood disorders (Chen et al., 2004; Chiaffarino et al., 2011;
Klemetti, Raitanen, Sihvo, Saarni, & Koponen, 2010) than the general population (e.g.,
CDC, 2011). These women also experience high rates of emotional vulnerabilities,
including stress reactivity and negative affectivity (Fassino, Piero, Boggio, Piccioni, &
Garzaro, 2002). A problematic aspect of this condition is that anxiety and depressive
symptoms in infertile women are not transient, meaning that symptoms do not always
subside during or after pregnancy. Research has shown that, in general, prenatal anxiety
is predictive of postpartum anxiety and depression, even after controlling for antenatal
depression (Heron, O’Connor, Evans, Golding, & Glover, 2004). Similar results have
been found when assessing women who had undergone fertility treatment; results
indicated that prenatal anxiety symptoms are predictive of post-partum depressive
symptoms (Punamäki et al., 2006).
Exacerbation of emotional symptoms. Anxiety and depressive symptoms are
likely to continue after women become pregnant and during postpartum (Austin, Tully, &
Parker, 2007; O’Connor, Heron, & Glover, 2002; O’Hara, 2009). For example, antenatal
anxiety symptoms have been predictive of later postpartum depression (Austin et al.,
2007). Furthermore, postpartum depression co-occurs with anxiety symptoms (for a
review see, O’Hara, 2009). Thus, anxiety symptoms during fertility treatment are not
generally transitional but may rather be a cyclical chronic burden that continues
throughout pregnancy and after delivery. Clearly, treatment prior to the development of
post-partum depression and/or anxiety symptoms is necessary in order to alleviate this
cyclical pattern.
6

Anxiety is a transitory emotional state that can be characterized by subjective
feelings of tension, apprehension, and is accompanied with the activation of the
autonomic nervous system and the hypothalamus-pituitary-adrenal axis (Spielberger,
Gorsuch, & Lushene, 1970; Tsigos & Chrousos, 2002). The function of anxiety is to
motivate the individual to avoid situations that could be potentially harmful (McNally,
1990; Mowrer, 1939). Because of the protective function of this emotion, being able to
experience anxiety and to have an appropriate stress response to a stressor is an important
adaptive function for the organism. However, excessive or irrational anxiety can have a
number of detrimental effects on people’s lives.
Animal studies have shown that high levels of anxiety induced by lack of food or
resources or lack of safety in the environment are responsible for the alteration of the
reproductive cycle in female rats and other mammals (Baker, Kentner, Konkle, SantaMaria Barbagallo, & Bielajew, 2006; Keen-Rhinehart et al., 2009; Kondoh et al., 2009).
The inhibition of fertility can be useful in situations when resources are scarce and the
ability to sustain an offspring are limited but it would have unnecessary repercussions if
the anxiety is caused by a maladaptive response to the environment as in the case of
individuals with low emotion regulation skills and with high anxiety sensitivity.
Anxiety can also have negative repercussions on the success rates of fertility
treatments. Studies on anxiety and reproduction have shown that elevated stress levels are
associated with increased uterine contractions (i.e., cramping) thereby obstructing
implantation (Chen et al., 2010; Fanchin et al., 1998). Specific to in vitro fertilization
(IVF), researchers have found that higher frequency uterine contractions on the day of
embryo transfer have resulted in fewer rates of implantation and pregnancy (Fanchin et
7

al., 1998; Ijland, Evers, & Hoogland, 1997; Vlaisavljevic, Reljic, Gavric-Lovrec,
Kovacic, 2001). Studies that measured anxiety, either preceding or during treatment (e.g.,
gonadotrophin-releasing stimulation cycle or prior to the first ART visit), found an
association between anxiety and lower pregnancy rates (Demyttenaere, Nijs, EversKiebooms, & Koninckx, 1992; Facchinetti, Volpe, Matteo, Genazzani, & Artini, 1997;
Smeenk et al., 2001). A recent meta-analysis reported individuals engaged in a
psychological intervention are nearly twice as likely to become pregnant as compared to
controls, and this increase in pregnancy rates appears to be related to a reduction in
anxiety symptomology (Frederiksen, Farver-Vestergaard, Skovgard, Ingerslev,
Zachariae, 2015). Anxiety during the early follicular phase and prior to oocyte retrieval
was significantly (negatively) associated with β-hCG concentration 15 days after oocyte
retrieval, and anxiety at the time of oocyte retrieval was also associated with lower
prolactin levels 15 days post retrieval and positive pregnancy outcome (Demyttenaere et
al., 1992). Moreover, an additional study measured the emotional response to anxiety
provoking pictures and the ability of individuals to compete a cognitive task while being
exposed to these anxiety provoking stimuli (i.e., Stroop Task), thereby testing anxiety
activation and regulation. Individuals who, on the evening prior to oocyte retrieval,
showed higher reactivity during the anxiety-provoking stimuli had higher rates of
pregnancy failure (Facchinetti et al., 1997). Furthermore, treatment studies aimed at
reducing anxiety have shown an improvement in pregnancy rates in the treatment group
as compared to the control group (Domar, Clapp, Slawsby, Dusek, et al., 2000; Domar et
al., 2011; Frederiksen et al., 2015; Ying, Wu, & Loke, 2016).

8

Another reason that treatment prior to pregnancy is beneficial is that some
psychotherapeutic techniques during pregnancy may be detrimental to the well-being of
the fetus. In particular, a recent review of the literature indicated that cognitivebehavioral treatments (CBT) involving exposure techniques may have negative
consequences on the development of the fetus (Arch, Dimidjian, & Chessick, 2012).
Although the research on exposure techniques in pregnant women is limited, as pregnant
women have generally been excluded from this research, Arch and colleagues (2012)
point out that further investigations are necessary before exposure techniques should be
implemented for pregnant women. To date, there are not enough data to understand the
impact of exposure during pregnancy. It is possible that exposure leads to elevated stress
and anxiety that can negatively impact the development of the fetus. Based on this,
infertile women who become pregnant may be precluded from receiving CBT for anxiety
even if their symptoms are likely to increase with the changes caused by pregnancy and
the additional stress caused by the fertility treatment.
In addition, although some medications can be taken while pregnant or
breastfeeding, often women refuse psychopharmacology given the limited knowledge of
the potential effects of these medication on the growing fetus (e.g., Goodman, 2009; Ross
et al., 2013; Turner, Sharp, Folkes, & Chew-Graham, 2008; Wisner et al., 2009). In fact,
there is evidence that pharmacotherapy for emotional disorders, such as benzodiazepines
(e.g., Calderon-Margalit, Qiu, Ornoy, Siscovick, & Williams, 2009; Wikner, Stiller,
Bergman, Asker, & Källén, 2007) and selective serotonin reuptake inhibitors (Domar,
Moragianni, Ryley, & Urato, 2013; Ross et al., 2013; Wisner et al., 2009), administered
during pregnancy, is associated with preterm birth, low birth weight and neonatal
9

complications. In summary, evidence indicates that women with an infertility diagnosis
are at higher risk for anxiety and mood disorders and have limited options for treatment
during pregnancy; therefore, making psychotherapy prior to pregnancy an ideal option.
Emotional symptoms detrimental long-term. In addition to the effects of
anxiety symptoms on the general mental health of the individual, anxiety symptoms
during pregnancy can also have detrimental effects on the physical and mental
development of the fetus. High levels of anxiety symptoms during pregnancy are
associated with a 2.12-fold increased risk of preeclampsia (Qiu, Williams, CalderonMargalit, Cripe, & Sorensen, 2009), a condition that leads to reduced blood flow to the
uterus that can affect normal development. Recent studies have shown that children born
after pregnancies complicated by preeclampsia were at 1.39-fold greater risk of anxiety
(Tuovinen et al., 2012); thus anxiety disorders during pregnancy may perpetuate anxiety
disorders in the next generation. Furthermore, prenatal anxiety has been found to be
predictive of a considerable amount of variance in infant illnesses and antibiotic use,
specifically, 9.3% for respiratory (i.e., breathing problems, asthma, influenza), 10.7% for
general (i.e., fever, eye discharge, infectious disease), and 8.9% for skin (i.e.,
pain/tenderness of skin, rash, impetigo) illnesses, as well as 7.6% for antibiotic use
(Beijers, Jansen, Riksen-Walraven, & de Weerth, 2010).

Purpose of Study
Anxiety symptoms are common in women experiencing infertility (e.g., Chen,
Chang, Tsai, & Juang, 2004), are exacerbated during fertility treatment (e.g., Gourounti
10

et al., 2010), and can remain persistent during pregnancy (e.g., Austin, et al., 2007;
Gourounti, 2015). Based on this, anxiety has the potential to negatively impact the health
of the mother and infant. It is thus critical that researchers explore more efficient and
appealing methods by which to deliver empirically supported psychological interventions
that can be provided to women experiencing infertility that reduce anxiety and/or
depressive symptoms. Based on this, the purpose of this study is to conduct a feasibility
pilot study that translates an empirically-based in-person group mind/body program for
fertility into an entirely internet-based program.
Brief overview of fertility treatment. Treatment for infertility varies and can
involve lifestyle changes (i.e., weight loss), medication (i.e., progesterone, clomiphene
citrate), surgery (i.e., repairing of blocked fallopian tubes), and/or other procedures (i.e.,
assisted reproductive technology; ACOG, 2015). Many of these treatments are used in
combination. Some of the most common fertility treatments include intrauterine
insemination (IUI), in vitro fertilization (IVF), and intracytoplasmic sperm injection
(ICSI). IUI is typically one of the first lines of treatment and includes the co-occurrence
of ovulation induction (i.e., drugs inducing a woman’s ovaries to release an egg) and
placing healthy sperm in the uterus during the “reproductive window” (ACOG, 2015;
Chandra, Martinez, Mosher, Abma, & Jones, 2005). Assisted Reproductive Technology
(ART) treatment is one of the most involved of the fertility treatments and includes any
procedure that entails the handling of both eggs and sperm. IVF is the most common
ART treatment, which involves ovulation induction, egg removal, combining healthy
sperm with the egg in the laboratory and then transferring the embryo to the uterus. ICSI
is another ART treatment that includes injecting a single healthy sperm into an egg and
11

then placing the embryo into the uterus (ACOG, 2013; Chandra et al., 2005). IVF and
ICSI can be thought of as cycles, since they consist of several steps over approximately
two weeks.
Use of infertility services. According to the Center for Disease Control and
Prevention (CDC; 2005), 12% of all women of reproductive age (7.3 million) used an
infertility service (i.e., advice, medical help to prevent miscarriage, fertility treatment) at
some point in their lives; whereas 74% of infertile women had sought infertility services
(Greil & McQuillan, 2004). The proportion of infertile couples seeking infertility related
care ranges between 42% to 76.3% (M =56.1%) in more developed countries (i.e., USA
and Europe) and 27% to 74.1% (M = 51.2%) in less developed countries (i.e., China and
India; Boivin et al., 2007); although this disparity is starting to shift as of 2010 there has
been an “explosion in IVF in the developing world” (for a review see, Inhorn & Patrizio,
2015, p. 415). Specifically, an average of 22.4% of women in more developed countries
received fertility treatment (Boivin et al., 2007) with an estimated 40% of infertile
women receiving fertility treatment in the USA (Greil & McQuillan, 2004). In 2002,
1.1% (700,000) and 0.3% (180,000) women in the USA underwent artificial insemination
(e.g., IUI) and ART (e.g., IVF and ICSI), respectively (Chandra et al., 2005). In 2007,
ICSI (63%) and IVF (37%) were the most common ART treatments (CDC, 2009).
Furthermore, nearly 40% of women had reported more than one ART cycle. Of the ART
cycles performed, 30% (43,412) resulted in a live birth (i.e., singletons or multiples).
Women who had reported completing more than one ART cycle were less likely to be
successful as compared to women undergoing their first cycle. Of the 50,421 clinical
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pregnancies that resulted from the ART cycles performed in 2007, 17% resulted in
miscarriage, stillbirth, induced abortion, or maternal death prior to birth (CDC, 2009).
Discontinuation of infertility services. ART treatment is an expensive, timeconsuming, and often distressing process (Brandes et al., 2009; Olivius, Friden, Borg, &
Bergh, 2004; Rajkhowa, Mcconnell, & Thomas, 2006; Smeenk, Verhaak, Stolwijk,
Kremer, & Braat, 2004; Verberg et al., 2008; Verhaak et al., 2005) where only an
estimated 30% of cycles are expected to result in a live birth (CDC, 2009) and drop-outs
due to psychological distress are high (Demyttenaere et al., 1992; Facchinetti et al., 1997;
Smeenk et al., 2001). An estimated 17% to 63% of couples drop out of IVF treatment (for
a review see, Domar, 2004; e.g., Land, Courtar, & Evers, 1997; Smeenk et al., 2004;
Verberg et al., 2008). Although poor prognosis and inability to pay for treatment were
originally thought to be the main reasons for treatment discontinuation (Cousineau &
Domar, 2007), more recent data suggest that physical or psychological burden of
treatment may be the most common reasons for drop-out (Verberg et al., 2008). In fact,
39-66% of individuals that dropped out of ART treatment attributed physical (i.e., “losing
a pregnancy,” “having oocyte retrieval,” and “having injections”) or psychological
burden (i.e., “I had had enough,” “emotional cost,” and “could not cope with more
treatment”) of treatment as the primary reason for their decision to drop out
(Hammarberg, Astbury, & Baker, 2001).
Research has shown that depressive symptoms are linked to problematic
outcomes for couples seeking fertility treatment. Depressive symptoms prior to fertility
treatment have been shown to be predictive of subsequent dropout rates (Smeenk et al.,
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2004). Additionally, individuals sometimes discontinue ART treatment due to
physician’s recommendation predicting poor prognosis. As a result, these individuals
indicate higher levels of anxiety and depressive symptoms as compared to those that
continue (Smeenk et al., 2004). As a consequence, depressive symptoms prior to fertility
treatment and as a result of physician recommendations about such treatment can lead to
drop out. Other reasons for discontinuation of treatment include: relational problems,
divorce, ethical objections to ICSI treatment after failed IVF treatment, adoption, poor
prognosis/response, practical reasons, medical problems, fears regarding the
complications of the procedure, and treatment independent pregnancy (Verberg et al.,
2008).

Infertility and Anxiety
As noted previously, co-morbid anxiety disorders are commonly seen among
infertile individuals. A wealth of research, mostly cross-sectional, has corroborated the
association between infertility and emotional problems, including anxiety, stress
reactivity, negative affectivity, and depression (Anderson, Sharpe, Rattray, & Irvine,
2003; Connolly, Edelmann, & Cooke, 1987; Facchinetti et al., 1997; Glover, Gannon,
Sherr, & Abel, 1996; Greil, 1997; Myers, 1990; Schmidt, 2006; Thiering, Beaurepaire,
Jones, Saunders, & Tennant, 1993; Verhaak et al., 2001). Worldwide (i.e., Asia, Europe,
Middle East, and North America), anxiety rates for women with an infertility diagnosis
appear to range between 10.9% to 23% (Chen et al., 2004; Chiaffarino et al., 2011;
Csemiczky, Landgren, & Collins, 2000; Drosdzol & Skrzypulec, 2008; Klemetti et al.,
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2010; Ramezanzadeh et al., 2004; Volgsten, Skoog Svanberg, Ekselius, Lundkvist, &
Sundström Poromaa, 2008, 2010). Rates varied primarily depending on whether the study
chose to assess and report specific disorders vs. symptom severity. For example, Klemetti
and colleagues (2010) reported rates of 11% for any anxiety disorder (i.e., panic disorder,
social phobia, agoraphobia, or generalized anxiety disorder), whereas Peterson and
colleagues (2007) reported that 24% of individuals with an infertility diagnosis had mild
to severe anxiety symptoms.
Compared to the general population, individuals with an infertility diagnosis have
been shown to have higher rates of anxiety symptoms. For example, Fassino and
colleagues (2002) demonstrated that fertile women had lower anxiety symptoms as
compared to infertile women. Other studies that have examined anxiety symptoms in
both fertile and infertile women have reported similar results (e.g., Drosdzol &
Skrzypulec, 2008). Furthermore, Klemetti and colleagues (2010) assessed both infertile
and fertile individuals and found that infertile individuals had a 2.67-fold increased risk
of meeting criteria for an anxiety disorder.
Similar to other chronic health conditions, infertile individuals may experience
risk factors that either contributed to the onset of anxiety symptoms or contributed to the
exacerbation/maintenance of these symptoms. This type of symptom development can be
characterized under a diathesis-stress model (Ingram & Luxton, 2005; Stanton & DunkelSchetter, 1991) in which predisposing factors (i.e., genetic and environmental) and the
degree of stress experienced by a person (i.e., infertility as the stressor) can trigger the
development of anxiety disorders. Infertility can be conceptualized as a life crisis, an
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unsolvable problem that is inhibiting important life goals and draining personal resources
(Stanton & Dunkel-Schetter, 1991). Specifically, infertility is often interpreted as
stressful, based on the fact that it is considered negative, unpredictable, uncontrollable,
and ambiguous (Gourounti, Anagnostopoulos, & Vaslamatzis, 2010). Infertile women
may experience both chronic and acute stressors associated with infertility. For instance,
women who have an infertility diagnosis continually experience the possibility that they
may never be able to become pregnant, thus leading to bouts of hopelessness of
becoming a parent. Moreover, women who engage in fertility treatment (i.e., IVF)
experience further acute financial, physical, and emotional stressors (Eugster &
Vingerhoets, 1999; Storck & Zieve, 2012; Verhaak et al., 2006). Specifically, ART
treatments (i.e., IVF) require many medical visits as well as multiple daily injections that
can lead to bruising, bloating, abdominal pain, headaches, and mood swings (Storck &
Zieve, 2012). The uncertainty of infertility and fertility treatment can evoke (or
perpetuate) anxiety, whereas the sense of loss and loss of control over the desired
outcome can lead (and/or exacerbate) to feelings of depression and hopelessness
(Gourounti et al., 2010).

Anxiety and Comorbid Depression
In both community and clinical samples of individuals, it is common to see that
over half of individuals have met criteria for both major depression and an anxiety
disorder at one point in their life (Ansseau et al., 2008; Brawman-Mintzer, Emmanuel,
Jarrell, & Ballenger, 1993; Brown & Barlow, 1992; Brown, Campbell, Lehman, Grisham,
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& Mancill, 2001; Kessler, Chiu, Demler, Merikangas, & Walters, 2005; Kessler, Nelson,
McGonagle, & Liu, 1996; Massion, Warshaw, & Keller, 1993; McLean, Asnaani, Litz, &
Hofmann, 2011; Moffitt et al., 2007; Wittchen, Zhao, Kessler, & Eaton, 1994; J. F.
Young, Mufson, & Davies, 2006). For example, Brown and colleagues (2001), using a
sample of 1,127 patients in a clinical setting, found that 30% met diagnostic criteria for
both a mood and anxiety disorder. Further evidence for a high comorbidity comes from a
longitudinal cohort study conducted by Moffitt and colleagues (2007) where 67% of
women in the sample met criteria for major depressive disorder in the past 12 months as
well as a previous or concurrent anxiety disorder. Additionally, 75% of women who had
met criteria for generalized anxiety disorder also had a previous diagnosis of major
depressive disorder. Furthermore, 72% of the sample who had met criteria for an anxiety
disorder at some point in their life also had met criteria for major depressive disorder.
Similar findings regarding current anxiety and depression disorder comorbidity rates have
been reported in other prevalence studies (Ansseau et al., 2008; Fichter, Quadflieg,
Fischer, & Kohlboeck, 2010). Based on these reports on comorbidity, it is possible that
anxiety and mood disorders may have more similarities than differences.
Although the research on infertile women and comorbid anxiety and depression is
sparse, the current evidence suggests that the likelihood of comorbidity among these
disorders in women experiencing infertility is similar to the general population. In fact,
depression symptoms are quite common among infertile women with rates ranging from
10.8% to 86.8% (Chen et al., 2004; Chiaffarino et al., 2011; Demyttenaere et al., 1998;
Domar, Broome, Zuttermeister, Seibel, & Friedman, 1992; Drosdzol & Skrzypulec, 2008;
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Lund, Sejbaek, Christensen, & Schmidt, 2009; Holley, Pasch, Bleil, Gregorich, Katz,
Adler, 2015; Nelson, Shindel, Naughton, Ohebshalom, & Mulhall, 2008; Newton, Hearn,
& Yuzpe, 1990; Ramezanzadeh et al., 2004; Volgsten et al., 2010, 2008). Similar to
studies assessing anxiety symptoms, the large range of rates of depression found in the
literature is due to study methodology differences such as specific diagnoses vs. symptom
severity. For example, Klemetti and colleagues (2010) reported rates of 11% for any
anxiety disorder (i.e., panic disorder, social phobia, agoraphobia, or generalized anxiety
disorder) and 8% for any mood disorder (i.e., dysthymia or major depressive disorder) in
infertile women whereas Demyttenere and colleagues (1998) reported that 54% of
individuals with an infertility diagnosis had mild depressive symptoms and 19% had
severe depressive symptoms. In terms of comorbid anxiety and mood disorders, one
study of infertile women found that of the 40.2% of women who had a psychiatric
disorder, over one-third of these women met criteria for both an anxiety and mood
disorder (Chen et al., 2004).
Prevalence rates of psychological treatment seeking. Fewer than 9% of
infertile women presenting at an infertility clinic reported currently seeing a therapist or
other mental health professional (Boivin, Scanlan, & Walker, 1999; Greil & McQuillan,
2004), which is far less than the rates of distressed infertile women. One study of women
attending infertility clinics found that over half (57%) of the responders indicated that
they would seek out counseling if it was offered to them, but only 14% of respondents
were offered treatment (Souter, Penney, Hopton, & Templeton, 1998). Furthermore, 73%
of women who have sought fertility treatment have reported dissatisfaction with the
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emotional support received during treatment (e.g., Souter et al., 1998; Sundby, Olsen, &
Schei, 1994), and 55% to 72% of women have indicated that they would have been open
to counseling if it was provided during their medical treatment (Daniluk, 1988; Laffont &
Edelmann, 1994; Sundby et al., 1994). However, one study found that, of the women
with a co-morbid infertility diagnosis and at least one DSM-IV diagnosis, only 18%
received some form of mental health care (Volgsten et al., 2008). For a comparison, one
national survey found that 38% of adults diagnosed with any mental disorder reported
receiving outpatient mental health services in the last 12-months (“SAMHSA,” 2012).
Based on this, it appears that treatment seeking behavior for mental health care may be
lower among infertile individuals with a mental health disorder. Furthermore, women
diagnosed with infertility reporting depressive symptoms were less likely to seek medical
advice for infertility than women with less severe symptomology (Herbert, Lucke, &
Dobson, 2010). In fact, one longitudinal study found that 30% of women who had trouble
conceiving did not seek medical advice related to infertility (Herbert et al., 2010). The
low rates of medical and psychological treatment-seeking behavior for women diagnosed
with co-morbid infertility and mental health problems adds to the chronicity of both
conditions.
Empirically supported psychological treatments. Since early 1980s, it has been
recognized that infertility could lead to emotional distress; therefore, the promotion of
psychological services for infertile individuals has been emphasized by researchers and
clinicians (Menning, 1980, as cited in Boivin, 2003). Although this emphasis promoted
the creation of many psychological interventions for infertile individuals, relatively few
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empirical studies have evaluated the effectiveness of psychosocial interventions to treat
those diagnosed with infertility and who are also experiencing anxiety with or without
depressive symptoms (Boivin, 2003; Haemmerli et al., 2008).
For the purpose of this review, only studies that assessed anxiety symptoms will
be reviewed, excluding studies that only examined state anxiety or momentary and
transitory anxiety (Spielberger, Gorsuch, & Lushene, 1970). Other inclusion criteria for
the review include: (1) infertile individuals; (2) face-to-face psychological intervention
(e.g., counseling, cognitive-behavioral therapy, educational, mind-body); (3) peerreviewed published study in English; (4) studies with independent samples; and (5)
anxiety as an outcome. I focused on face-to-face interventions for this review because
they are the most common and studied mode of intervention. Furthermore, internet-based
interventions were typically developed and tested as an extension of these already tested
face-to-face interventions and based on this will not be incorporated in this review, but
will be reviewed later in the document (see Internet-Based Treatments, below).
This literature review produced 15 studies that met the criteria listed above. Of
importance, none of these studies, with the exception of two which examined depression
symptoms/diagnosis only (Faramarzi, et al., 2008; Koszycki, Bisserbe, Blier, Bradwejn,
& Markowitz, 2012), utilized an eligibility criterion of elevated anxiety and/or depression
symptoms. As shown in Table 1, the interventions were divided into four types:
counseling, stress-reduction, mind-body, and cognitive-behavioral interventions.
Counseling interventions incorporated interpersonal and/or cognitive therapeutic
principles that specifically focused on infertility, such as identifying and correcting
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cognitive distortions and beliefs specifically regarding infertility. The majority of these
counseling interventions were not effective at reducing anxiety and/or depressive
symptoms (Connolly et al., 1993; De Klerk et al., 2005; Emery et al., 2003; Liswood,
1995). This may be due to the fact that these interventions were extremely brief and were
narrowly focused on cognitions related to infertility. Two counseling interventions that
were longer in duration resulted in a reduction of anxiety and depressive symptoms
(Koszycki et al., 2012; Stewart et al., 1992).
Stress reduction interventions included relaxation techniques, such as autogenic
training, involving short regular exercises that incorporate visualization (O’Moore,
O’Moore, Harrison, Murphy, & Carruthers, 1983). Two studies investigated treatments
that fit the criteria of stress reduction/relaxation interventions and these interventions
both resulted in reduction of anxiety symptoms (McNaughton-Cassill, Bostwick, Arthur,
Robinson, & Neal, 2002; O’Moore, et al., 1983); however, no reduction in depressive
symptoms was found in the O’Moore et al. (1983) study.
Mind-body therapies focus on the connection between the brain, mind, body, and
behavior and how this impacts overall health (for a review, see Wahbeh, Elsas, & Oken
2008). Specifically, mind-body interventions often include relaxation techniques such as
hypnosis, meditation, yoga, biofeedback, tai chi, and visual imagery. Three of the four
studies testing the effectiveness of the Mind/Body Program for Fertility showed
promising results indicating a reduction in both anxiety and depressive symptoms
(Domar, Seibel, & Benson, 1990; Domar, Zuttermeister, Seibel, & Benson, 1992; Domar,
Clapp, Slawsby, Kessel, et al., 2000). This mind-body intervention stands apart from
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many others in behavioral-health as it combines relaxation techniques including
mindfulness with cognitive-behavioral principles. Also, the literature shows a cognitivebehavioral group intervention that combined, psycho-education surrounding infertility as
well as depressive symptomology, progressive muscle relaxation (a type of relaxation
technique), and cognitive-behavioral principles. This intervention resulted in a reduction
in anxiety and depressive symptomology (Faramarzi et al., 2008). Based on this review, it
appears that the mind-body intervention (that includes psychoeducation regarding
physical/emotional health, relaxation techniques [including mindfulness], and cognitivebehavioral principles), originally developed to prevent the anticipated increase in
psychological distress as the duration of infertility increases (Domar, Clapp, Slawsby,
Kessel, et al., 2000), has the most empirical support for reducing both anxiety and
depressive symptoms in women experiencing infertility; however, interventions that are
comparable in duration to this specific mind-body program that involve cognitive
techniques with or without the combination of relaxation techniques also show promise.
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Table 1. Intervention characteristics, sample size, and outcome for infertility studies reviewed
Duration
RandomPositive
Studies
Country
Format
Sample Measure
(weeks)
ized
Outcome
Counseling Specific to Infertility
Connolly et
al., 1993

UK

3

Couple

Yes

De Klerk et
al., 2005

The
Netherlands

3

Couple

Yes

Emery et al.,
2003

Switzerland

1

Couples

Yes

Koszycki et
al, 2012 1

Canada

12

Individual

Yes

Liswood,
1995

Canada

6

Individual/
Couple

Yes

Stewart et al.,
1992

Canada

8

Group

Yes

USA

9

Couple

Yes

Ireland

10

Group

No

37 Tx
45
Ctrls
21 Tx
19
Ctrls
86 Tx
82
Ctrls
15 Tx
16
Ctrls
18 Tx
18
Ctrls
18 Tx
18
Ctrls

POMS

None

HAD

None

BDI
STAI

None

HRSDAnxiety
BDI

HRSDAnxiety
BDI

SCL90-R

None

BSI
BDI

BSI anxiety
BDI

BAI
BDI

BAI
(women
only)

BAI

BAI

Stress Reduction Only
McNaughtonCassill et al.,
2002
O’Moore et
al., 1983
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41 Tx
37
Ctrls
17 Tx
12
Ctrls

Table 1. (cont’d)
Mind-Body
Chan et al.,
2006 2

Hong
Kong,
China

4

Group

Yes

69 Tx
115
Ctrls

STAI

None

47 Tx
48
Ctrls

BDI;
HAD;
HRSD;
POMS

POMSanxiety/
depression

POMS
STAI

POMS
anxiety/
depression

POMS
STAI

POMSanxiety/
depression

CAS
BDI

CAS

STAI
SDS

None

DASS

None

Domar et al.,
2000 3

USA

10

Group

Yes

Domar et al.,
1990 3

USA

10

Group

No

Domar et al.,
1992 3

USA

10

Group

No

54 Tx

41 Tx

Cognitive-Behavioral
29 Tx
30
Ctrls
64 Tx
Unclear
Lee, 2003
Taiwan
Individual Yes
68
a
Ctrls
32 Tx
Mosalanejad
Iran
12
Group
Yes
33
et al., 2012
Ctrls
1
Only included participants that had a primary diagnosis of depression.
Faramarzi et
al., 2008 1, 4

Iran

10

Group

Yes

This program involved psychoeducation regarding “traditional Chinese medicine” and “Chinese
philosophical writings,” stress-reduction training, and other activities including signing, journal
writing, and drawing.
3
These programs involved a combination of mind-body (i.e., relaxation, including mindfulness)
and cognitive-behavioral techniques.
4
This intervention described itself as a “CBT program” + progressive muscle relaxation.
a
The relaxation training included a 40 minute educational video describing self-hypnosis and
muscle relaxation training that not all participants completed. Additionally, the participants
received varying number of CBT sessions. The program did not involve psychoeducation
regarding physical and/or psychological health specifically; although it did offer psychoeducation
regarding the “therapeutic process.” Based on the description provided in the manuscript, it is
unclear who provided the counseling and their level of training.
Note: Studies, Mixed = psychoeducation regarding fertility treatment, relaxation and cognitivebehavioral techniques. Sample, Tx = Treatment, Ctlrs = Controls, *One control group were
fertile individuals. Measurements, BDI = Beck Depression Inventory; CAS = Cattell Anxiety
Scores; DASS = Depression, Anxiety, and Stress Scale; HAD = Hospital Anxiety and Depression
Scale; HRSD = Hamilton Rating Scale for Depression; STAI = Spielberger State Anxiety
Inventory; POMS = Profile of Mood Scale; SCR-90 = Symptom Checklist Revised -90; SDS =
Zung Self-reported Depression Scale. Positive outcome indicates a positive intervention effect.
2
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Limitations of currently available treatments. One of the biggest limitations of the
existing literature is the paucity of well-controlled treatment studies that have targeted
anxiety in infertile women. The focus of studies testing psychological treatment of
anxiety has been infertility-induced distress (for a review see, Boivin, 2003; also see,
Matthiesen et al., 2011; McQueeney, Stanton, & Sigmon, 1997; Stewart et al., 1992).
Only a handful of these studies have specifically assessed for clinical symptoms (i.e.,
anxiety and depression) and, of those, only a few have found a meaningful reduction in
symptoms (Domar et al., 1990; Domar, Zuttermeister, et al., 1992; Domar, Clapp,
Slawsby, Kessel, et al., 2000; Faramarzi et al., 2008; Koszycki, Bisserbe, Blier,
Bradwejn, & Markowitz, 2012; Stewart et al., 1992), raising the question whether the
treatment dose was adequate (for a review see, Boivin, 2003; Hämmerli, Znoj, & Barth,
2009). A recent meta-analysis assessing the efficacy of psychological interventions for
infertile individuals showed that the majority of trials for anxiety disorders did not use
evidence-based (Hämmerli et al., 2009). Further, the evidence-based treatments that
showed a reduction in anxiety and/or depressive symptoms, most did not to conduct
further trials and/or replicate their results. In fact, the mind-body program conducted by
Domar and colleagues (Domar et al., 1990; Domar, Zuttermeister, et al., 1992; Domar,
Clapp, Slawsby, Kessel, et al., 2000) is the only empirically supported treatment with
replicated results.
The theoretical model (i.e., diathesis-stress) utilized for this study posits that
infertility (diagnosed after one year of failed attempts to become pregnant) activates
anxiety vulnerabilities including cognitive/emotional vulnerabilities and biological
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vulnerabilities. The activation of these vulnerabilities leads to the development of severe
emotional symptomology. For the individual who seeks fertility treatment and is able to
become pregnant, a number of additional stressors are added by the hormonal and
situational (i.e., lack of sleep, disruption of daily routine) changes during pregnancy and
postpartum. Such stressors exacerbate the symptoms and, as reviewed above, may play a
role in the transmission of the anxiety disorder to the offspring. The author proposes an
intervention for women experiencing infertility, implemented before or during fertility
treatment, aimed at reducing anxiety and/or depression symptoms and promoting wellbeing (and potentially the offspring of these women). In addition to greater motivation to
complete the treatment to possibly facilitate pregnancy (e.g., Chan & Ng, 2006; Domar et
al., 2011; Domar, Clapp, Slawsby, Dusek, et al., 2000; Stewart et al., 1992; Strauss et al.,
2002), treating the anxiety symptoms at this junction may have the beneficial effect to
inoculate the individual from the progressive worsening of the symptoms. Based on the
high comorbidity between anxiety and depressive symptoms in infertile women and the
fact that a mind/body intervention tailored for infertile women has been shown to reduce
both anxiety and depressive symptoms, the author chose to pursue this transdiagnostic
approach to reducing symptomology associated with both (i.e., anxiety and mood) in
women with a comorbid infertility diagnosis.

Transdiagnostic Treatments
Anxiety and mood symptoms under the umbrella of emotional symptom
severity. Anxiety and mood symptoms can both be considered as indicators of broadband
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emotional symptomology. An emotional disorder can be defined as the tendency for an
individual to experience heightened affect in response to the environment and thereby
interpret this increase in affect as negative and harmful (for a review see Brown &
Barlow, 2009). In general, individuals, who evaluate and then reject their own emotional
responses as either unacceptable or inappropriate, have a heightened chance of suffering
from emotional symptoms (e.g., Campbell-Sills, Barlow, Brown, & Hofmann, 2006). It is
important to note that most of the research and conceptualization in this area has focused
on disorders. Classifying anxiety and mood symptoms as emotional dysregulation
highlights their commonalities rather than focusing on their differences. As classification
of individuals into a disorder is not part of the current project, I will discuss symptoms
rather than diagnoses and consider a transdiagnostic approach for treatment of these
broadband emotional symptoms.
Support for this transdiagnostic perspective comes from (1) the frequency of comorbidity of anxiety and mood disorders (Ansseau et al., 2008; Brawman-Mintzer et al.,
1993; A. Brown & Barlow, 1992; T. Brown et al., 2001; Kessler et al., 2005, 1996;
Massion et al., 1993; McLean et al., 2011; Moffitt et al., 2007; Wittchen et al., 1994; J. F.
Young et al., 2006); (2) common risk factors associated with anxiety and depression
(Aldao & Nolen-Hoeksema, 2010; Barlow, Allen, & Choate, 2004; Hankin, Abramson,
Miller, & Haeffel, 2004; Hofmann, Sawyer, Fang, & Asnaani, 2012; Rhebergen et al.,
2011); (3) evidence of overlapping processes (Bird, Mansell, Dickens, & Tai, 2013; T.
Brown, Chorpita, & Barlow, 1998; Mansell, Harvey, Watkins, & Shafran, 2009); and (4)
findings suggesting that treatments for anxiety or depression tend to reduce
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symptomology for non-specific emotional symptoms (T. Brown, Antony, & Barlow,
1995; T. Brown et al., 2001).
Existing treatment identified as “transdiagnostic”. A transdiagnostic treatment
approach to emotional symptoms would target the underlying commonalities of these
anxiety and depression symptoms and possibly make treatments targeted to a specific set
of symptoms less necessary targeted to a specific set of symptoms. In fact, the ideal
transdiagnostic psychotherapy would be effective in reducing the symptomology
associated with all emotional symptoms (i.e., including anxiety and/or mood) and
enhancing the well-being of an individual. Researchers have posited that there are
cognitive and behavioral processes that are shared among several emotional symptoms
and thereby the potential of a transdiagnostic treatment to reduce symptomology is due to
the design of the treatment to target core “higher order” factors (i.e., negative and
positive affect; Mansell et al., 2009). This is in contrast to an emotion-specific approach,
which posits that the key onset and potentially maintenance factors are specific to one
emotion (e.g., anxiety) and differ across emotions thereby necessitating several
therapeutic approaches. Taking a transdiagnostic approach in psychotherapy has many
benefits including simplifying the assessment and clinical training processes and
enhancing interventions by potentially making them briefer and more effective
(Farchione et al., 2012; for a review see, Mansell et al., 2009). Specifically,
transdiagnostic treatments may enhance dissemination by providing a treatment that
clinicians can easily master, creating one evidence-based treatment that may be both
more efficient and effective for the treatment of complex clinical cases with one or more
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emotional components (Farchione et al., 2012). In essence, the transdiagnostic approach
takes a parsimonious viewpoint to human behavior by integrating universal rather than
distinct principles that decrease distress and increase functioning and well-being.
Mansell and colleagues (2009) identified four approaches that could be considered
transdiagnostic, which they labeled (1) “limited range, multiple process,” (2) “symptombased,” (3) “universal, single process,” and (4) “universal, multiple process.” The
“transdiagnostic approach limited range multiple process” can be defined as a range of
cognitive and behavioral processes that are associated with the maintenance of many
emotional symptoms. “Symptom-based” transdiagnostic approaches identify mechanisms
behind specific symptoms that explain psychological distress regardless of type of
emotion. “Universal, single process” is one process responsible for the maintenance of
psychological distress across many emotions in contrast to “universal, multiple process”
that accounts for many maintenance processes.
One of the most discussed transdiagnostic treatments in the field currently is the
Unified Protocol (UP) for Transdiagnostic Treatment of Emotional Disorders (Barlow,
Ellard, et al., 2011; Barlow, Farchione, et al., 2011). This “limited range, multiple
process” can be defined as a cognitive-behavioral treatment that focuses on emotional
processes and was developed to target all disorders or severe symptoms associated with
emotion dysregulation, including anxiety and mood disorders or symptoms. The
treatment involves psychoeducation surrounding emotions, tracking and observing
emotions and physical sensations, restructuring maladaptive cognitive appraisals,
changing maladaptive action tendencies associated with emotions, preventing emotion
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avoidance, and emotional exposure techniques (Barlow, Ellard, et al., 2011; Barlow,
Farchione, et al., 2011).
An open clinical trial using the UP approach included 18 participants who met
diagnostic criteria for up to three (M = 1.94) anxiety and/or mood disorders at pretreatment. Participants completed 8-15 UP treatment sessions with results indicating an
improvement in depressive and anxiety symptom severity as well as a decrease in
negative affect post-treatment (Ellard, Fairholme, Boisseau, Farchione, & Barlow, 2010).
Regardless of improvements in symptom severity and a reduction of negative affect,
diagnoses on average still remained at a clinical level post-treatment.
A second open clinical trial involved the modification of the initial UP treatment
manual by going into more depth with each of the treatment modules and reordering the
modules to be more “clinically useful.” This open trial consisted of 15 participants who
met diagnostic criteria for up to four (M = 2.2) anxiety and mood disorders pre-treatment
and completed 12-18 UP sessions, Results showed a reduction in symptom severity and
negative affect. Additionally, 74% of participants in this second open-trial study showed
clinically meaningful change and 64% of participants with comorbid disorders achieved
responder status and high end-state functioning (HESF) on comorbid disorders (Ellard et
al., 2010).
Further evidence for support of a transdiagnostic treatment for emotional disorders
comes from a randomized controlled trial of 37 patients who met diagnostic criteria for
an anxiety disorder and up to four (M = 2.16) additional anxiety and/or mood diagnoses.
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Participants were assigned to a treatment or wait-list control group. Participants in the
treatment group completed an average of 15.26 UP sessions. Results from this study
indicated improvements in clinical symptom severity and positive affect, reductions in
negative affect, and 50% to 59% of participants achieving either a HESF or responder
status at post-treatment as compared to 0% of controls (Farchione et al., 2012).
Interestingly, in contrast to the open-trials (Ellard et al., 2010), results from Farchione
and colleagues (2012) showed large treatment effects with regards to positive affect. The
authors posited that this change may be due to the revisions made in the second open trial
(Ellard et al., 2010) in which a specific emphasis on reducing avoidance of positive
emotions was added to the UP treatment manual. Based on the findings of Fanchione et
al. (2012) the UP treatment protocol appears more effective than a wait-list control group
for the treatment of emotional disorders or symptom severity.

A New Perspective on an Empirically Tested Treatment
Although not commonly discussed under the umbrella of transdiagnostic
treatments, mindfulness-based treatments can also be considered transdiagnostic in nature
(Baer, 2007). A recent meta-analysis has shown that mindfulness interventions are
moderately effective for reducing anxiety and depressive symptoms individually, as well
as co-morbid anxiety and depression (Hofmann, Sawyer, Witt, & Oh, 2010). The
development of mindfulness skills can increase self-focused attention, thus making one’s
attention more flexible, non-reactive, and unbiased (Baer, 2007). Furthermore,
mindfulness has been shown to reduce the occurrence of rumination and experiential
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avoidance (Baer, 2007). Self-focused attention, rumination, and experiential avoidance
are all considered transdiagnostic processes (Harvey, 2004), that appear to contribute to
the possible onset and/or maintenance of a range of psychological problems, including
anxiety and depression (Baer, 2007).
What is mindfulness? Mindfulness is a practice that originated from religious
practices, specifically Buddhism (Thera & Jayatilaka, 1972). In the last few decades
mindfulness has been increasing in popularity as a way of improving well-being and
decreasing symptomology associated with many physical and psychological disorders
(Chiesa & Serretti, 2010; Keng, Smoski, & Robins, 2011). Jon Kabat-Zinn (1994)
describes mindfulness as “paying attention in a particular way, on purpose, in the present
moment, and non-judgmentally.” In several interviews, Kabat-Zinn emphasizes that one
of the most challenging aspects of mindfulness is the ability to take a non-judgmental
stance, highlighting that humans have “ideas and opinions about virtually everything”
(Szalavitz, 2012, para. 18). Crediting a behavioral perspective, Kabat-Zinn insists that the
lives of humans are governed by conditioned behaviors; if we like something we
approach it and if we do not like something we avoid it. This way of learning has
functional purpose in human’s lives, such as approaching a love interest to mate and
avoiding foods that smell bad to prevent being poisoned. Unfortunately, this behavior can
also have dysfunctional qualities as well. For instance, individuals who are emotionally
avoidant may fail to live their valued life (i.e., pursue fertility treatment) for fear of
failure (i.e., anxiety). Thus, the underlying assumption of mindfulness is that, if we can

32

attend to our present moment without judgment, we can experience life as it really is,
resulting in a healthier (i.e., less negative) perspective.
Components of mindfulness. In order to better understand the effects of
mindfulness, researchers have recently sought to operationalize Kabat-Zinn’s definition
of mindfulness to explain (1) how mindfulness practices can affect change and (2) the
relationship between mindfulness and other constructs (i.e., stress, quality of life).
Several models have been proposed, including models that include one or more possible
components of mindfulness. Brown and Ryan (2003, p. 824) proposed that “mindfulness
is inherently a state of consciousness” and thereby sought to define and create a
measurement that could identify the unique aspect of mindfulness that (i.e., were
different from all other psychological phenomena).
Other researchers have posited that mindfulness is a multifaceted construct that
combines several related skills. Bishop et al. (2004) proposed a two component model
that highlights (1) self-regulation of attention to the present moment and (2) adoption of a
curious, open, and accepting stance. For instance, sustained attention on breathing can be
thought of as a way to anchor attention to the present moment, thereby gaining a greater
ability to experience the passing thoughts, feelings, and sensations of each particular
moment. Shapiro et al. (2006) added intention as the third component to the model
(Bishop et al., 2004), which they defined as one’s personal motivation or vision on
reasons to engage in a mindfulness practice. Specifically, Shapiro and colleagues (2006)
proposed a linear model of well-being can be promoted through practicing mindfulness,
which can lead to changes in perception, and improvements in self-regulation,
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clarification of values, and flexibility (i.e., cognitive and behavioral). Carmody et al.
(2008) later tested this model and found partial support. Specifically, results showed that
the components proposed (i.e., self-regulation, flexibility, values clarification, and
exposure) improved after practicing mindfulness for a set period of time; however,
mindfulness and perceiving were found to highly overlap and flexibility was found to be
a partial mediator between mindfulness and well-being. In addition, not enough evidence
was found to determine if intention was a relevant component of mindfulness.
Other researchers (Segal et al., 2002) have described mindfulness as having four
elements including observing the current moment, acceptance, non-judging, and nonreactivity. Lastly, Linehan (1993) described mindfulness as having two overarching
components that can be described as mindful actions and qualities, each including three
elements: observing, describing, and participating.
In addition to determining the components that best define mindfulness, many
researchers have described mindfulness as a trait-like variable in which individuals can
be described as mindful or not (K. Brown & Ryan, 2003). Mindful individuals are people
was take a curious and nonjudgmental approach to their daily life and are more aware and
present in their lives. Regardless of the assumption that mindfulness is a trait-like
phenomenon (similar to personality), evidence shows that mindfulness can be practiced
and individuals can learn to experience mindful states (i.e., mindfulness as state-like).
Thus, it is possible that practicing mindfulness can lead to the individual becoming more
mindful and this can have positive effects on other aspects of life and well-being. Based
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on this assumption, many mindfulness interventions have been tested with the goal of
decreasing negative symptoms and improving overall well-being.
Mindfulness-based treatments. Since the year 2000, new therapeutic practices
have emerged, either incorporating mindfulness as a module of the treatment or as the
primary mode of treatment. These new therapies have been identified as the third-wave in
behavior therapy, following behavior therapy itself (i.e., first wave; e.g., Wolpe, 1969)
and cognitive-behavioral therapy (i.e., second-wave; e.g., Beck, 1979; Hayes, 2004). In
fact, third-wave therapies, including acceptance and commitment therapy (ACT; Hayes et
al., 2004), dialectical behavior therapy (DBT; Linehan, 1993), mindfulness-based
cognitive therapy (MBCT; Segal et al., 2002), and mindfulness-based stress reduction
(MBSR; Kabat-Zinn, 2003), are considered empirically supported treatments (Ost, 2008).
In general, cross-sectional and treatment studies have reported that mindfulness and
mindfulness-based therapies are associated with a decrease in anxiety, depression,
substance abuse, chronic pain and borderline personality disorder symptoms (Baer &
Krietemeyer, 2006; Hofmann et al., 2010; Kabat-Zinn, Lipworth, & Burney, 1985;
Lynch, Trost, Salsman, & Linehan, 2007) and improvements in emotion regulation and
well-being (K. Brown & Ryan, 2003; Vujanovic, Bonn-Miller, Bernstein, McKee, &
Zvolensky, 2010). Based on the findings to date, mindfulness appears to show promise in
promoting overall quality of life and reducing suffering in general.
Mindfulness-based treatments and emotional disorders. A meta-analysis assessing
the effectiveness of mindfulness treatment in reducing anxiety and depressive symptoms
reported a large effect size (Hofmann et al., 2010). Given the beneficial effects of
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mindfulness practice in decreasing anxiety and improving emotion regulation,
mindfulness could be a beneficial treatment for women diagnosed with infertility seeking
ART treatment who are also experiencing anxiety.
Mindfulness, infertility, and co-morbid emotional disorders. Mindfulness has
been recommended in the infertility literature as a coping strategy for reducing infertility
related stress (Domar, 2002; Stanton & Burns, 2006). Indeed, some infertility clinics are
already offering various 1-day, 8-week, and customized mindfulness-based stress
reduction treatments in their clinics (FPNC, 2013). The mind/body intervention (Domar
et al., 1990; Domar, Zuttermeister, et al., 1992; Domar, Clapp, Slawsby, Kessel et al.,
2000) previously discussed is the only empirically-based treatment that incorporates
elements of both mindfulness and cognitive principles (i.e., cognitive restructuring),
similar to that of MBCT, and has been tested with infertile individuals. Although the
mind/body intervention shows promise in reducing anxiety and depressive symptoms in
this population, more research is needed to assess if this intervention is effective,
particularly with more impaired individuals.

Barriers to Seeking Psychotherapy and a Possible Solution
As previously mentioned, face-to-face psychotherapy is the most common
intervention available for infertile individuals. However, many women diagnosed as
infertile report being unable or unwilling to access this specialized intervention due to
barriers such as fear of being dismissed from fertility treatment, fears of stigmatization,
skepticism regarding efficacy, comfort level (i.e., too shy or scared), cost, uncertainty of
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who to contact, and difficulty with scheduling sessions (Boivin et al., 1999; Wischmann,
2005, 2008). Studies assessing the acceptability of internet-based interventions found that
individuals who chose this type of treatment did so out of convenience,
privacy/anonymity, cost, waiting time, and transportation (e.g., Leibert & Archer, 2006).
Specific to infertility, anonymity may be the most appealing aspect of internet-based
treatments and this modality may provide a safe forum for individuals to obtain treatment
and not feel stigmatized (Aarts et al., 2012). Based on this, internet-based interventions
appear to be promising in both the health and mental health fields, specifically, for
infertile individuals experiencing anxiety symptoms.

Internet-Based Treatments as a Solution to Treatment-Seeking Barriers
Overview of internet-based interventions. Regular internet usage has become a
part of many people’s daily lives. In fact, 71.7% of the total U.S. households reported
accessing the internet in 2011 and more than 85% of those under the age of 45 reported
access either through smartphones and/or home internet (File, 2013). Moreover, the
internet is a place that allows for information sharing, virtual communication and shared
participation. Internet-based interventions are thus a viable modality that could be
integrated into individuals’ current internet-usage. Internet-based interventions can be
defined as self-guided programs that are executed by means of a prescriptive online
program operated through a website and used by consumers seeking physical-and mentalhealth related assistance (Barak, Klein, & Proudfoot, 2009). Some internet-based
interventions are considered self-guided and are typically designed to promote general
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positive change (i.e., emotional, cognitive, or behavioral). These self-guided web based
interventions tend to be highly modular and structured. Self-guided internet-based
interventions that have a human-support element, provided in a couple of minutes to
several hours, tend to have a greater effect as compared to those that are only self-guided
(e.g., Andersson, Carlbring, Berger, Almlöv, & Cuijpers, 2009). The human support
element is typically not in real time (Hedman, Ljótsson, & Lindefors, 2012).
Benefits of internet-based interventions. In general, internet-based interventions
have several benefits, including accessing hard-to-reach populations, convenience, and
cost-effectiveness (Manhal-Baugus, 2001). For example, the internet can reach people
who choose not to attend in-person treatment or are without many options to treatment
providers, such as those who live in rural areas. Furthermore, internet-based interventions
can be extremely convenient for those who have scheduling conflicts, difficulties with
transportation, or disabilities. Lastly, once developed, internet-based interventions are
comparatively easy to implement, have great fidelity, and tend to be significantly more
affordable than face-to-face therapy.
General effectiveness of internet-based treatments. Although early internetbased interventions were hampered by limitations in technology and several
methodological deficits, recent internet-based interventions have shown promise.
Specifically, internet-based interventions designed to address panic disorder, social
anxiety disorder, posttraumatic stress disorder, mild to moderate depression, and
headache could be considered empirically supported (Andersson et al., 2009). For
example, a meta-analysis assessing cognitive-behavioral internet-based interventions
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reported a large effect size for reduction of anxiety symptoms and a small effect size for
reduction of depression symptoms (Spek et al., 2007). In fact, Andersson and colleagues
(2009) reported effect sizes found for internet-based interventions are quite similar to
effects seen in face-to-face interventions. For instance, no differences have been found
for the treatment of panic disorder, depression, or tinnitus when comparing internet-based
and in-person interventions (for a review, see Andersson et al., 2009). At this time, it
appears that internet-based adult-focused cognitive-behavioral interventions can reduce
emotional symptomology as compared to wait-list controls; however, in contrast to the
Andersson et al. (2009) findings, researchers have cautioned against reaching conclusions
regarding the comparison of internet-based interventions and in-person interventions and
called for more quality research comparing the two modalities directly (Arnberg, Linton,
Hultcrantz, Heintz, Jonsson, 2014; Peñate & Fumero, 2015). Nevertheless, internet-based
treatment modalities appear to be a promising and effective mode for reducing anxiety
and depressive symptoms.
Specific-effectiveness of internet-based treatments for co-morbid infertility
and anxiety. A large proportion of individuals experiencing infertility are highly
motivated to better understand their condition as well as the current research on and
potential remedies for infertility. In fact, many infertility patients are already looking for
resources and/or support on the internet (Cousineau & Domar, 2007). Similarly to the
review the author has presented on in-person interventions, the author provides a brief
review of internet-based studies that assessed anxiety symptoms with or without
depressive symptoms. Other inclusion criteria for the review include: (1) infertile
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individuals; (2) internet-based psychological intervention (e.g., counseling, cognitivebehavioral therapy, educational, mind-body); (3) peer-reviewed published study in
English; (4) independent studies with independent sample sizes; and (5) anxiety as an
outcome with possible inclusion of depressive symptoms as well. For a summary of
studies see Table 2.
Four studies were found that utilized an internet-based intervention and assessed
mental health changes (Cousineau et al., 2008; Haemmerli, Znoj, & Berger, 2010;
Sexton, Byrd, O’Donohue, & Jacobs, 2010; van Dongen, Nelen, Kremer, & Verhaak,
2016) and only two of these studies assessed anxiety and depression symptoms
specifically (Haemmerli et al., 2010; van Dongen et al., 2016). Although all four studies
are summarized in Table 2, only the two assessing anxiety and depression symptoms will
be reviewed here.
Haemmerli and colleagues (2010) conducted a self-guided internet-based
intervention and utilized measures assessing anxiety and depressive symptoms. This
intervention, titled the “Child Wish Online Coaching” program, was described as having
cognitive-behavioral components, including progressive muscle relaxation and behavioral
activation, both behavioral techniques. It is unclear how the intervention integrated
cognitive therapeutic components; however, the program involved having participants
share their cognitions surrounding their motives, hopes and fears for having a child and
unrealistic expectations. Furthermore, participants were asked to analyze how they
experienced stress and their stressors. Lastly, the intervention integrated coping
strategies, communication techniques, and information regarding their diagnosis and
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potential medical treatments. Participants were provided with an e-therapist (holding
either a master’s degree in clinical psychology or a bachelor’s degree in psychology and
supervision from the master’s degree clinician); however, any interaction between
participants and e-therapists were initiated by the participant and only 65% of participants
made contact with the e-therapist. An exploratory analysis, including only participants
with elevated depressive symptoms, resulted in moderate to large between-group effect
sizes of d = 0.37 for anxiety symptoms and d = 0.67 for depressive symptoms, favoring
the treatment group over the control group.
A recent study by van Dongen and colleagues (2016) conducted an e-therapist
guided, individually tailored, internet-based intervention that also utilized a measure
assessing combined anxiety and depressive symptoms. This intervention, titled
Digicoach, was described as assigning participants to one or more available modules
depending on their needs as assessed by the e-therapist. The three modules (each
involving five sessions) were: "stress management,” "depressed mood," and “social
support.” The “stress management” module focused primarily on identifying stress and
stress reduction through unspecified relaxation techniques. The “depressed mood”
module involved identifying and restructuring automatic thoughts in order to alter
emotions and behavior. Lastly, the “social support” module involved enhancing
communication with social supports, identifying individual needs, and encouraging
balance between social obligation and support. Two registered counselors certified in
fertility care were assigned as e-therapists and held an in-person intake meeting with each
of the participants and engaged in weekly contact with the participants delivered by
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email. All feedback from the e-therapists was supervised by a clinical psychologist.
Although participants with highly elevated anxiety/depressive symptoms were excluded
from the study, results still revealed a significant group difference for women showing
clinically relevant scores for depression and/or anxiety favoring the intervention group.
The success of the Child Wish Online Coaching and Digicoach, further supports
investigating the efficacy of internet-based interventions programs. In addition, several
areas of improvements can be identified after a close analysis of the Haemmerli et al.
(2010) and van Dongen et al. (2016) studies. The Haemmerli et al. (2010) protocol
involved both men and women and did not assess their reproductive medical treatment
status, thus reducing the ability to generalize the results to the general population of
infertile women. Furthermore, although the intervention seemed promising and appeared
to incorporate some cognitive-behavioral principles, it had not been tested in an in-person
format and therefore further testing is needed to assess intervention effectiveness. The
van Dongen et al., (2016) protocol had many strengths, including providing individually
tailored modules and e-therapist support. However, this study had a number of limitations
including the following: the protocol eliminated those with elevated anxiety/depression
symptoms; did not measure anxiety and depression separately; was only offered to a
specific group of infertile women (i.e., starting their first ART cycle); did not specify
results as they related to module (i.e., “stress management,” “depressed mood,” or “social
support;”); did not report the length of time between treatment completion and the final
assessment which could possibly influence outcomes; and although evidence-based
strategies appeared to be included in the design of the program they did not appear to
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have been tested in-person. To add to the extant knowledge on treating anxiety and mood
symptoms in women with infertility problems, future research should consider expanding
on the further development of interventions that have already shown to be effective at
reducing anxiety and depressive symptoms in individuals diagnosed with infertility.
Based on the reviewed literature, the Mind/Body Program for Fertility (Domar et
al., 2000), incorporating both mindfulness and cognitive treatment components, appears
to show the most potential in being a transdiagnostic treatment to reduce anxiety and
depressive symptoms. Moreover, this approach appears ideal for the translation into a
brief e-therapist guided internet-based treatment.
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Table 2. Intervention characteristics, sample size and outcome for internet-based studies reviewed
Country

Type/
Name

Duratio
n

Format

Random
-ized

Cousineau
et al., 2008

USA

Mindbody

60-90
min a

Selfguided

Yes

49 Tx
FPI
49 Ctrls

FPI

Haemmerli,
et al., 2010

Switzerland

Child
wish
online
coaching

2 wks b

Selfguided

Yes

60 Tx
CES-D
64 Ctrls STAI-T

CES-D
STAI-T

Sexton
et al., 2010 1

USA

Coping
with
infertilit
y

8 wks c

Selfguided

Yes

16 Tx
FPI
18 Ctrls SCR-90

SCL-90

van Dongen
et al., 2016 2

The
Netherlands

Digicoach

5-15
wks d

etherapis
t guided

Yes

61 Tx
HADS
59 Ctrls

HADS *

1

Sample

Measur
e

Positive
Outcom
e

Studies

Only included participants that had a score of 20 or less on the BDI, including only normal or mildly
depressed participants.
2
Only included participants with a score of 13 or less on the HADS, including only normal or borderline
depressed/anxious participants.
a
In total it was estimated that the self-guided website took 60-90 minutes to navigate and could be
completed in one sitting.
b
The intervention phase was considered to be 2-weeks, however the women were advised that they were
likely to derive benefit with continued practice of intervention strategies, but were informed that they
could use the site as much or as little as they would like.
c
Information was grouped into 13 sessions, however participants were free to decide the pace at which
they complete the sessions. Each page and session builds upon the previous, therefore participants could
only gain access to the second module after completing the first.
d
The intervention was an individualized program that consisted of three different modules: "stress
management" (i.e., relaxation training), "depressed mood" (i.e., cognitive restructuring), "social support"
(i.e., identifying individual/social needs and enhancing communication with partner). Depending on
need, participants could be assigned to one or more modules. Each module was intended to last 5 weeks.
*
Significant differences were found between the intervention and control groups at T3 ("3 months after
ART" ~16 weeks after the start of intervention), but not at T2 ("after pregnancy test" ~ 6 weeks after the
start of intervention).
Note: Sample -- Tx = Treatment, Ctlrs = Controls. Measurements -- CES-D: Center for Epidemiologic
Studies for Depression Scale; FPI = Fertility Problem Inventory (assesses fertility related stress); HADS
= Hospital Anxiety and Depression Scale; STAI-T = Spielberger State Anxiety Inventory Trait Only;
SCL-90 = Symptom Checklist Revised -90 (assesses general stress)
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Purpose
Internet-based interventions have the potential to address many of the previously
stated barriers, including increased privacy to reduce perceived stigma, cost effectiveness
(as compared to face-to-face therapy), and flexibility to be adapted around the patient’s
busy schedule. For individuals who live in rural areas or have difficulties accessing
mental health care (i.e., individuals that are physically disabled and/or lack of
transportation), internet-based interventions are an ideal option to access treatment from a
distance. Based on these premises, it is posited that offering an empirically-based
internet-delivered intervention to reduce anxiety symptomology will be accepted and
considered satisfactory among women experiencing infertility. b
This study was a Stage I pilot study that translates an existing in-person
Mind/Body Program for Fertility into an internet-based intervention. As with other Stage
I studies, this consisted of pilot and feasibility testing, program development (in this case,
web-development), adherence/competence measure development for new and untested
treatments, as well as basic behavioral/psychological research (Onken, Blaine, & Battjes,
1997). Following guidelines highlighted by Moore and colleagues (2011), the broad
purpose of this study was to (1) contribute to the development and design of future
research, (2) develop and clarify research hypotheses to be studied, (3) identify barriers to
future study completion, and (4) provide estimates of the expected rates of participant
attrition. In addition, as delineated next, I examined if the intervention is associated with
reductions in anxiety and depression as well as increased levels of mindfulness.
Specifically, the goals of this pilot are to demonstrate that (1) the mind/body program
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developed for in-person implementation can be translated into an internet-based
treatment; (2) an acceptable number of women experiencing infertility are willing to be
randomized to the treatment or wait-list groups and can be identified and recruited; (3)
participants will report appropriate levels of acceptance and readiness to engage in the
internet-based intervention as measured by retention rates, treatment adherence, and
treatment satisfaction; and (4) participants will demonstrate reduction over the course of
treatment in anxiety and depression symptom severity and enhanced mindfulness. This
treatment paradigm provides women experiencing infertility with skills and strategies to
manage infertility-related distress that they are asked to practice during treatment
sessions as well as at home between sessions. The skills and strategies include the
following: (1) knowledge regarding the relationship regarding stress and infertility as
well as lifestyle and infertility; (2) relaxation techniques including diaphragmatic
breathing and Hatha Yoga; (3) mindfulness; (4) cognitive restructuring; (5) stress
reduction strategies (e.g., humor); (6) listening and communication skills; (7) strategies
for emotional expression and effective coping with anger; and (8) assertiveness training
and goal-setting skills. Thus, this study aimed to demonstrate that an internet-based
approach, based on an existing in-person intervention, can help reduce infertility-related
anxiety symptoms as well as depressive symptoms.

Rationale
This study provided an internet-based version of an established empirically based
mind-body intervention for women experiencing infertility. Evidence for the
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effectiveness of the intervention will give women in rural areas or otherwise
unable/unwilling to pursue in-person psychotherapy an option that will be seen as
satisfactory and effective at promoting mindfulness and reducing psychopathological
symptoms associated with infertility. The current study aimed to address some of the
limitations previously highlighted in the review of the literature by (1) using a
manualized, evidence-based treatment tailored for women diagnosed with infertility that
has been effective in reducing anxiety and depressive symptoms; (2) including some
participants with heightened levels of anxiety symptoms and conducting analyses with
them separately; and (3) including individuals with co-morbid depressive symptoms.
Internet-based interventions have the potential to address many of the previously
stated barriers, including increased privacy to reduce perceived stigma, cost effectiveness
(as compared to face-to-face therapy), and flexibility to be adapted around the
individual’s busy schedule. For individuals who live in rural areas or have difficulties
accessing mental health care (i.e., individuals that are physically disabled and/or lack of
transportation), internet-based interventions are an ideal option to access treatment from a
distance. Based on these premises, it is posited that offering an empirically based
internet-delivered intervention to reduce anxiety symptomology will be accepted and
considered satisfactory among infertile women.

Hypotheses
The stress of infertility exacerbates anxiety symptoms in the individual and, as
reviewed above, may play a role in the transmission of anxiety to the child. The proposed
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intervention will be provided to the women experiencing infertility before or during
fertility treatment. The author expects that participants in the intervention group will be
motivated to complete the intervention because (1) research has shown that reduction in
anxiety symptoms has been associated with a significantly higher live birth rate (Domar,
Clapp, Slawsby, Dusek, et al., 2000) and (2) treating the anxiety symptoms at this
junction may have the beneficial effect of inoculating the individual from the progressive
worsening of the symptoms. To test this model, this study collected data on anxiety,
depressive symptoms, and mindfulness skills.
Hypothesis 1. Consistent with other RCTs, the author hypothesized that
participants will accept this intervention method, and sought to demonstrate that
acceptance in two ways. First, the author will demonstrate acceptance through retention
and adherence rates similar to prior studies. Haemmerli and colleagues (2010) conducted
an internet-based intervention with infertile patients and found that 86% of the
intervention and 82% of control group completed the post-treatment assessment.
Additionally, they reported that 72% of participants in the treatment group completed at
least half of the interventions sessions. van Dongen and colleagues (2016) defined
compliance of their internet-based program for infertile women to be at least five sessions
(defined as one module) and 10 or more logins and found that 48% met compliance (i.e.,
adherence). Additionally, 38% of the intervention group and 58% of the control group
(48% total) completed the post-treatment assessment (described as “T3” assessment).
Based on this evidence, the author expects to find similar retention and adherence rates
by demonstrating that at least 48% of participants will complete the post-intervention
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assessment (i.e., retention) and 48% of the intervention group will have completed five or
more internet-based modules (i.e., adherence, out of 10 modules).
Second, the author sought to demonstrate acceptance through client satisfaction.
The author proposes that, consistent with other research, the average satisfaction rates for
the current study will be approximately 68 out of 100 as measured by the Client
Satisfaction Inventory-Short Form (CSI-SF; Leibert & Archer Jr, 2006; McMurtry &
Hudson, 2000). This is in line with previous studies reporting satisfaction rates for online
interventions, in this case interventions guided by a therapist mostly through email or
instant messaging. Additionally, client satisfaction was assessed module by module, by
asking participants the ease and helpfulness of each of the modules. The author also
expects that at least 50% of participants will report that the modules on average were at
least moderately helpful as previous internet-based studies involving infertile women
reported that 50% rated their intervention as moderately to very satisfying (van Dongen
et al., 2016).
Hypothesis 2. Previous in-person mind/body RCTs for women experiencing
infertility have reported between group significant differences as well as large betweengroup effect sizes (d = 0.54 and .69) favoring the intervention for reducing anxiety
(Domar et al., 2000). Based on this, the author hypothesized that a large between group
differences and effect size for anxiety symptoms that favors the intervention group. The
author examined anxiety symptoms of participants for the sample as a whole (similar to
Domar et al., 2000) and for those with elevated symptoms at pre-intervention in
secondary analyses.
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Hypothesis 3. Since anxiety symptoms are often comorbid with depressive
symptoms, both in the general population and with women experiencing infertility, it is
expected that depressive symptoms will be present in this sample. The in-person
mind/body RCT has reported significant between-group differences and medium to large
effect sizes (d = .37 - .73) for depressive symptoms, favoring the intervention group
(Domar, Clapp, Slawsby, Kessel et al., 2000). Thus, the author hypothesized that between
group differences and a medium effect size for depressive symptoms that favors the
intervention group would be found.
Hypothesis 4. Although changes in mindfulness have yet to be assessed in
studies utilizing mind-body treatments that have incorporated both relaxation training and
cognitive-behavioral techniques specifically, other mindfulness interventions (i.e.,
mindfulness-based stress reduction and mindfulness-based cognitive therapy, both inperson and internet-based) have shown significant between-group differences and
medium to large effect sizes (d = .24-.90) in facets of mindfulness as measured by the
Five-Factor Mindfulness Questionnaire (e.g., Baer, Carmody, & Hunsinger, 2012; Brotto,
Basson, Smith, Driscoll, & Sadownik, 2015; Cavanagh et al., 2013; Vøllestad, Sivertsen,
& Nielsen, 2011). Based on this, the author hypothesized that between-group differences
and at least a medium effect size for changes in mindfulness that favors the intervention
group would be found.
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METHODOLOGY

Overview
This randomized controlled trial (RCT) was conducted following the guidelines in
the Web-Based Treatment Research Cycle (Web-TRaC). Web-TRaC provides
researchers steps in order to move from treatment development (Step 1) to RCTs (Step 2;
Enock & McNally, 2013). For this study, a total of 71 women were recruited and
randomized. Specifically, 36 women who identified as infertile were randomized to the
intervention group and received the internet-based Mind/Body Program for Fertility. The
additional 35 were randomized to the wait-list group, used as the control group. Primary
outcome (i.e., anxiety) and secondary outcome (i.e., mindfulness and depressive
symptoms) variables were assessed at screener (anxiety only), pre-, mid-, and postintervention assessment. In following the Web-TRaC suggested protocol, the face-to-face
Mind/Body Program for Fertility (Domar et al., 1990) was translated into an internetbased program that included the use of text, audio, video, interactive elements, and builtin homework. Web-TRaC treatment development, unlike traditional psychotherapy
development, maintains great fidelity since deviations from the protocol are not possible
(Enock & McNally, 2013). Based on the recommendations, researchers should start out
with minimal contact internet-based interventions that incorporate most interaction with
participants, including assessment, online (Enock & McNally, 2013).
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Participants
The sample consisted of 71 participants. Consistent with RCT studies, the sample
is described in the initial parts of the Results section.
Inclusion criteria were that participants were (1) 18 years old or older; (2) primary
infertility diagnosis (i.e., has not given birth and was not currently pregnant); (3) could
read and write in English; (4) had internet access; (5) had elevated anxiety symptomology
as measured by a Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988) of
10 or greater; (6) no current diagnosis for an active psychotic disorder, eating disorder,
substance abuse or dependence and did not report current suicidal/homicidal ideation or
intent (assessed by the MINI International Neuropsychiatric Interview for DSM-IV); (7)
no psychotropic medication changes in the last month; (8) was not currently receiving
psychotherapy; (9) and had not completed nor was currently engaged in a Mind/Body
Program.

Compensation
Control participants received $10 for completing the pre- assessment as well as
$15 upon completion of the online post-assessment as an incentive to complete the study.
Similar compensation has been noted in other RCT’s with the face-to-face Mind/Body
Program for Fertility (Domar et al., 2011). As further incentive, control participants were
offered the opportunity to engage in the internet-based Mind/Body Program after they
completed the post-assessment. The current Mind/Body Program for Fertility is offered
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as an in-person group format commercially for $780 (“FAQ’s,” 2013); participants
randomized to the intervention group received the intervention itself as compensation.

Measures
Screener questions. Screener questions included (1) do you and/or your partner
meet criteria for an infertility diagnosis; (2) are you fluent in written/spoken English; (3)
do you have regular access to the Internet; (4) types of psychotropic medications and
duration of use; (5) psychotherapy status; and (6) have you participated in or are you
currently participating in a Mind/Body Program.
Demographic variables. Participants completed a demographic section during
the pre-intervention assessment. These demographic variables included: age, marital
status, duration of relationship, partners gender, number of children (i.e., step-, foster, or
adopted), education, yearly household income, ethnicity, employment, months trying to
conceive, fertility diagnosis, current stage of fertility treatment, insurance coverage of
fertility treatment, number of miscarriages, and number of minutes engaged in relaxation
techniques per week.
Credibility/Expectancy for Improvement Scale (CEQ; Borkovec & Nau, 1972;
Devilly & Borkovec, 2000). The CEQ is a six-item questionnaire designed to assess the
credibility and the expectancy for intervention. The CEQ has been revised to be
appropriate for this sample, which includes items such as “how logical does this type of
treatment seem to you” (i.e., Credibility subscale) and “how confident would you be that
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this treatment would be successful in eliminating symptoms related to anxiety and/or
depression” (i.e., Expectancy subscale). Questions are rated on a 9-point Likert scale.
Scoring of the CEQ consists of standardizing the items and then summing the three
individual items for each subscale (i.e., Credibility and Expectancy).This scale has
demonstrated factors that are stable across multiple populations and high internal
consistency for both the credibility (α = .81 to .86) and expectancy (α = .79 to .90;
Devilly & Borkovec, 2000) scales. The alpha coefficient for the credibility and
expectancy scales for the current sample was .83 and .89, respectively.
Internet-Based MINI International Neuropsychiatric Interview for DSM-IV
(MINI; Sheehan et al., 1998). The MINI is a standardized structured diagnostic interview
that can evaluate for meeting DSM-IV-TR criteria for most psychiatric diagnoses. The
MINI assesses for a range of psychiatric conditions, include anxiety, mood, substance,
eating, personality as well as suicidality and psychosis. Interrater reliability is good with
all of the kappa values above 0.75, and 70% .90 or higher (Sheehan et al., 1998). Testretest kappa values, except for current mania (.45), are good with the majority of values
being above .75 (Sheehan et al., 1998). The MINI on average has shown adequate
concordance with Structured Clinical Interview for DSM-III-R interviews and the
Composite International Diagnostic Interview diagnoses (Sheehan et al., 1998). Recently,
the MINI has been translated online and is now provided in an internet-based electronic
interview format with the same features as the original MINI (In Home Screening, 2016).
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Hypothesis 1 Variables
Retention . Originally, participants who completed the post-assessment were to
be counted as retained. However, as will be delineated, this was expanded from postassessment to mid-assessment.
Adherence Consistent with prior studies (e.g., Haemmerli et al., 2010; Van
Dongen et al., 2016), participants in the intervention group who completed five or more
modules of the internet-based Mind/Body Program were considered to have adhered to
the intervention.
Ongoing assessments. Participants were asked at the beginning of every session
if they (1) completed the practice exercises at home since the last module. Additionally,
at the end of each intervention module, participants were asked to comment on their
ability to complete the module, including ease (0 “easy”, 1 “moderately challenging”, 2
“challenging”) and helpfulness of module (0 “completely unhelpful”, 1 “slightly helpful”,
2 “moderately helpful”, 3 “very helpful”).

Hypothesis 2 Variable
Beck Anxiety Inventory (BAI; Beck et al., 1988; Beck, Steer, Beck, &
Newman, 1993). The BAI is a 21-item self-report measure used to assess somatic or
panic-related anxiety symptoms. Example items include “feeling hot,” “nervous,” and
“fear of losing control.” Individuals are asked to rate their symptoms of anxiety over the
past week on a 4-point Likert scale from 0 (“not at all”) to 3 (“severely; I could barely
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stand it”). The BAI has excellent internal consistency (α = .92) and good test-retest
reliability after 1-week, r = .75 and convergent validity (Beck et al., 1988). The alpha
coefficient for the current sample was .91, .88, and .98 at the screener, pre-assessment,
and mid-assessment, respectively. Research has shown people who meet DSM criteria for
an anxiety disorder have a mean score of 10.3 (SD= 7.5) or higher on the BAI (e.g.,
Leyfer, Ruberg, & Woodruff-Borden, 2006; Muntingh et al., 2011). Therefore, a score of
10 or higher (Beck & Steer, 1999) is indicative of mild anxiety and an appropriate cut-off
score, consistent with a variety of anxiety disorders (e.g., Eack, Singer, Greeno, 2008;
Leyfer et al., 2006; Muntingh et al., 2011).

Hypothesis 3 Variable
Beck Depression Inventory – 2nd Edition (BDI-II; Beck, Steer, Ball, & Ranieri,
1996). The BDI-II is a 21-item self-report measure used to assess cognitive, affective,
and physical depressive symptoms. Questions include content such as sadness, guilt,
disappointment, and loss of energy. Participants are asked to rate each item on a 4-point
Likert scale from 0 (not endorsed) to 3 (endorsed at maximum severity). The BDI-II has
been shown to have good validity (α = .90) and high one-week test-retest reliability, r =
.93 (Beck et al., 1996). The alpha coefficient for the current samples was .91 at the preassessment and .93 at the mid-assessment.
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Hypothesis 4 Variable
Five-Factor Mindfulness Questionnaire (FFMQ; Baer, Smith, Hopkins,
Krietemeyer, & Toney, 2006). The FFMQ is a 39-item self-report measure used to assess
a trait-like tendency to be mindful in daily life. It has five subscales including observe
(i.e., notice or attend to internal and external stimuli), describe (i.e., mentally note stimuli
with words), awareness (i.e., attend to their actions in the moment), non-judgmental (i.e.,
refrain from evaluating inner experiences), and non-reactive (i.e., not get caught up with
their thoughts and feelings, allowing them to come and go). Examples of the five
subscales include: “when I’m walking, I deliberately notice the sensations of my body
moving” (observe); “I’m good at finding words to describe my feelings” (describe);
“when I do things, my mind wanders off and I’m easily distracted” (awareness); “I
criticize myself for having irrational or inappropriate emotions” (non-judgmental); and “I
perceive my feelings and emotions without having to react to them” (non-reactive). Each
question on the FFMQ is rated on a 5-point Likert scale ranging from 1 (“never or very
rarely true”) to 5 (“very often or always true”), with higher scores indicating greater
mindfulness. The FFMQ total score and all FFMQ subscales have shown adequate to
good internal consistency with alpha coefficient scores ranging from α = .75 to .91 (e.g.,
Baer et al., 2006; Van Dam, et al., 2009). Test-retest reliability on the FFMQ has yet to
be reported. The FFMQ has been shown to have significant relationships in the predicted
direction with a variety of related constructs (e.g., difficulties in emotion regulation,
neuroticism, psychological symptoms; Baer et al., 2006). Furthermore, an increase in
FFMQ scores in general has been found to fully mediate the relationship between total
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formal practice meditation time and perceived stress as well as psychological symptoms
(Carmody & Baer, 2008). The alpha coefficient for all FFMQ items in the current
sample was .91 at the pre-assessment (subscale alpha coefficient scores ranged from α =
.87 - .93) and .93 at the mid-assessment (subscale alpha coefficient scores ranged from
.82 – .95).

Current Study Design and Procedures
Design. This pilot project was a randomized control trial using a between groups
repeated measures experimental design. The two independent variables were intervention
(intervention vs. wait-list control) and assessment (pre-assessment, and as will be
explained later, mid-assessment).
Recruitment. Recruitment efforts were carried out in numerous ways.
Specifically, selected fertility care providers (e.g., primary care facilities, OBGYN
offices, yoga studios, acupuncture offices, etc.) throughout the country were contacted by
email/mail and invited to assist in recruitment efforts by posting professionally
designed/printed study flyers in their facilities and including them in new patient packets.
Recruitment text was also provided and requested to be added to organizational
websites/Facebook pages when applicable. Lastly, a brief recruitment script was offered
to facility staff to help aid staff in providing information about the study fertility patients.
The recruitment material included a brief description about the study and study
requirements along with a study email address.
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Part way through the study, due to limited recruitment success, recruitment efforts
were extended to other channels that had the potential of coming in contact with couples
struggling with infertility (e.g., social media websites [i.e., Facebook], websites
specifically geared toward infertile couples [i.e., Resolve], crowdsourcing [i.e., Amazon
Mechanical Turk], broadcast emails [e.g., special interest groups/email lists], emailing
colleagues and acquaintances outside of OBGYN that may know either infertile couples
directly or individuals that work with infertile couples, and online communities [e.g.,
Craigslist, Front Porch Forum]).
Although several months of recruitment efforts were attempted, nearly all
participants were successfully recruited within three months. Recruitment success was
primarily due to expanding recruitment to multiple medium channels (see Table 4 in
Results). Social media websites (i.e., Facebook) and forum/blogs geared towards infertile
couples (i.e., Resolve.org) were the most successful recruitment avenues for this study. In
fact, nearly one third of participants reported hearing about the study through
Resolve.org.
Interested individuals were asked to email the study coordinator to obtain more
information and the link to the online screener that were used to (1) provide interested
individuals with more information, (2) obtain consent, and (3) determine eligibility.
Enrollment. Due to initial difficulties in recruitment efforts, inclusion criteria
were relaxed in order to further promote recruitment for the study. Therefore, it was no
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longer required that participants had an elevated BAI score or that they were not
receiving psychotherapy.
Participants who qualified for the study and expressed interest in the internetbased Mind/Body Program were asked to complete an online pre-assessment. Participants
who completed the online pre-assessment were randomized to an experimental (i.e.,
intervention) or a control (i.e., wait-list) condition. Participants assigned to the
intervention condition were asked to complete the 10 week (one module per week)
internet-based Mind/Body Program and assigned practice exercises (i.e., homework).
These individuals were asked to complete minimal assessments weekly (during each
module) and an online mid- and post-assessment. For the intervention group, the midassessment occurred after five weeks and the post-assessment occurred after completion
of the 10 modules. The control group completed an assessment at approximately the same
time points as the intervention group’s mid- (~five weeks) and post- (~10 weeks)
assessments.
The wait-list group was provided with the opportunity to participate in the
internet-based Mind/Body Program after completing the post-assessment for the purposes
of (1) providing incentive to remain in the study and (2) providing the intervention to
those who are interested; however, data from the wait-list group’s post-assessment (as
well as data from the intervention group’s post-assessment) were not used in the analyses
for this dissertation except to report how many completed the assessment.
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Approval from the Committees on Human Research at the University of Vermont
was obtained prior to data collection.

Intervention and Translation
Alice Domar’s, Ph.D., in-person group format Mind/Body Program for Fertility
(Domar et al., 1990; Domar, Zuttermeister et al., 1992; Domar, Clapp, Slawsby, Kessel,
et al., 2000) was translated into an internet-based program. This face-to-face program is
most often presented by at least one therapist in a group setting over the course of 10
weeks. Nine of the sessions last for two hours (typically on a weekday) and one session
lasts the entirety of the day (typically on a weekend). Partners are invited to three of the
10 sessions. This treatment paradigm provides women struggling with infertility skills
and strategies to manage infertility-related distress that they are asked to practice during
intervention sessions as well as at home between sessions. Participants are asked to come
up with three physical or psychological symptoms that they are asked to monitor
throughout the course of the program (e.g., improved communication with partner,
reduction in stress, accept whatever the future may hold). In addition, participants are
assigned homework at the end of each session (i.e., relaxation response practices, writing
exercises, cognitive restructuring assignments) and asked to track their progress (number
of minutes of relaxation response exercise, mini exercises, and physical activity) as well
as certain health related information (i.e., alcohol and caffeine consumed; alternative
treatments they engaged in during the week, such as acupuncture). Overall, the
Mind/Body Program for Fertility incorporates relaxation training, cognitive restructuring,
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methods for emotional expression, and psychoeducation regarding the intersection
between emotional (i.e., stress, anxiety, depression) and physical health (i.e., nutrition,
physical activity, and additional therapeutic modalities).
Individuals typically spend the first part of each group checking in with the group
providing weekly updates regarding medical visits or treatments, issues that arose in the
preceding week surrounding fertility, and overall how each individual is feeling. Often,
one person each session shares a more in-depth version of her fertility story with the
group. The remaining structure of each group typically consists of a group relaxationresponse exercise (i.e., body-scan, mindfulness, progressive muscle relaxation, Hatha
Yoga), a paired discussion of the homework (relaxation-response practice), introduction
to what the session involves, group or paired exercises, and ends with a shorter
relaxation-response exercise (i.e., imagery, deep breathing). The topics for each session
involve the following: (Session 1) psychoeducation regarding the physiology of stress,
relaxation-response, and the relationship between stress and fertility; (Session 2)
diaphragmatic breathing, mini-relaxation-response exercises, and effective
communication strategies; (Session 3) psychoeducation surrounding self-empathy and
compassion; (Session 4) psychoeducation involving the intersection between nutrition,
physical activity, and fertility (typically providing a nutritional lunch) as well as
introduction to mindfulness and mindfulness practices; (Session 5) more about physical
activity and an introduction to Hatha Yoga; (Session 6) stress management and cognitive
restructuring; (Session 7) all day session devoted to yoga, exercise, and couples
cognitive-behavioral exercises; (Session 8) cognitive restructuring and positive
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affirmations; (Session 9) psychoeducation and skills regarding emotions, emotion
regulation (i.e., anger management; partners are invited to attend mini support group);
and (Session 10) the importance of assertiveness, a review of the previous modules,
follow-up information, and goal setting (e.g., Domar et al., 2013; Domar et al., 1990).
The skills taught in this program have been shown to reduce anxiety, depression, and
overall fertility-related distress (Domar et al., 1990; Domar, et al., 1992; Domar, et al.,
2000).
The internet-based Mind/Body Program for Fertility was designed to mirror the
in-person intervention in structure and content; thus, as with the in-person protocol, this
internet-based intervention included information and exercises structured into 10 separate
modules. Each module includes text, audio, video, interactive elements, and pdf
downloads for homework completion. The development team included the creator of the
Mind/Body Program for Fertility (i.e., Alice Domar, Ph.D.), a technical advisor, several
research associates, and the author. Most of the pre-programming conceptualization
involved only Dr. Domar and the author. Prior to translating the program, Dr. Domar
invited the author to attend her three-day training program for clinicians interested in
integrating the Mind/Body Program for Fertility into their practice. Translation began
with developing an outline for each of the modules. After the team agreed on the overall
outline, each module was drafted to involve the exact content laid out with a screen-byscreen plan, including identifying the form of multimedia (i.e., text, audio, images, video,
and other types of interactive content) used.
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Content for the internet-based Mind/Body Program for Fertility was derived from
the Mind/Body Program for Fertility manual (Domar, 2013); the books, Healing Mind,
Healthy Woman: Using the Mind-Body Connection to Manage Stress and Take Control
of Your Life (Domar & Dreher, 1997) and Conquering Infertility: Dr. Alice Domar’s
Mind/Body Guide to Enhancing Fertility and Coping with Infertility (Domar & Kelly,
2004); material from a variety of relevant peer-reviewed journal articles and/or credible
health organizations (i.e., CDC; World Health Organization; American Heart
Association); and content from fertility-related websites (i.e., Resolve.org;
Ourbodiesourselves.org). Content and structure of each module was discussed over
several meetings and finalized prior to implementation and design of the internet-based
intervention.
A few challenges arose when translating the program from in-person to internetbased. The first challenge was the fact that there are a number of group and paired
elements to each of the exercises and sessions for the in-person group format. One of the
main intents of this internet-based intervention is that participants could start immediately
and do each of the modules at their convenience. This structure does not depend on
waiting for a certain number of participants to be recruited before starting participants in
the program (unlike most in-person group formats) and also allows participants to go at
their own pace. In order to account for the initial sharing portion of the in-person
program, an infertility story was included at the beginning of each module and
participants were asked to share during each module information regarding their fertility
treatment status, new and good things happening in their life, their ability to engage in
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homework throughout the week, their feelings in general (i.e., anxiety, stress), and any
other thoughts/feelings they had about what was going on in their life or about the
program. Participants were also asked to write about their fertility story during Modules 9
and 10, which was intended to model the sharing portion at the beginning of each inperson module as well as a writing exercise presented in session nine.
In order to equate the therapist involvement across participants and based on the
recommendations for internet-based therapeutic programs (e.g., Andersson, Carlbring,
Berger, Almlöv, & Cuijpers, 2009), the author served as the e-therapist for the program.
The author is a master’s level pre-doctoral clinician who specializes in emotional
disorders with a special focus in women’s health. The author provided feedback to each
participant after each module. All feedback followed the same overall format, including:
a summary of the previous module; addressing any questions, concerns, or problems
participants’ were having; commenting on the content they provided in each module (i.e.,
progress in achieving personalized goals, completing homework, health-related
behaviors, and comments/information provided reflection on the various exercises in
each module); providing a graph of their progress (i.e., anxiety symptom severity scores
per module as rated by the BAI); reminding participants about the homework (as well as
links to access the downloads of the week and the audio if they forgot to save them
during the program); and introducing the next module’s content and any items they may
need to best complete the next module (i.e., chocolate for a mindfulness practice, yoga
mat, or a timer). Within this feedback, participants were also provided with a link to
begin the next module. Dr. Domar supervised the feedback provided to the participants.
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Feedback was provided to participants an estimated seven days after they completed the
previous module in order to allow them time to complete each week’s homework. The
feedback became more time-consuming than originally predicted and therefore four other
clinicians (one doctoral and three pre-doctoral) assisted in drafting feedback using the
approved template structure. All feedback was either written or reviewed and edited by
the author prior to being sent to participants. Participants were asked to complete the
module within seven days of receiving the link. When participants did not complete the
module within seven days, they were sent a reminder email to help maintain engagement
and to offer support. Participants were encouraged at the end of each module and in each
of the e-therapist responses to contact the e-therapist through email if they had any
questions, concerns, or issues. Some participants addressed their concerns in the
comment section of the modules and others would reach out to the e-therapist separately
via email.
Another challenge when translating the program was how to condense the all-day
session into a session that would take participants 60 minutes or less to complete. This
goal was achieved by spreading out some of the in-person exercises over a few modules.
In addition a 60 minute movie on stress and stress management presented in the in-person
program was not included in the internet-based version of the program in order to keep
the modules under 60 minutes in length. Other than the movie, all other aspects of the allday session were incorporated into the internet-based program.
The author designed each module to follow the same structure of the in-person
Mind/Body Program for Fertility. Additionally, to enhance usability each of the 10
66

internet-based modules shared a similar structure. Each module consisted of an
introduction of the content included in the upcoming module; progress notes to track
individual goals (set at the beginning of the program) and homework completed the
previous week; BAI; multiple choice questions involving content of the previous module;
review of the previous module; a fertility story; participant ratings on how positive,
negative, or neutral their week had been; reflection on what new and good thing
happened during the week; relaxation response exercise; content for that module; mini
relaxation exercise; homework for the week; and downloads for the week (typically
including reading material and the audio for the relaxation exercises they were introduced
to in that module). Homework was assigned in each session. Homework included:
practicing relaxation response exercises (ideally for twenty minutes two times a day),
mini relaxation exercises (ideally up to five minutes a day anytime participants became
stressed or anticipated becoming stressed), and other Mind/Body Program for Fertility
practices (i.e., couple communication exercises, increase of pleasant activities, writing
exercises, and cognitive practices).
Unlike the in-person program, participants were encouraged to have their partners
join them for every module. Exercises in each of the modules were modified when
necessary to account for the involvement of the partner. For example, the cognitive
restructuring exercises included space for both partners to participate. Additionally,
couples yoga was incorporated into one of the modules to mimic the in-person program.
Individuals who did not complete this module with their partner were provided video
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instructions for an individual yoga practice and the audio for couple’s yoga to do as
homework.
Implementation and design of the internet-based Mind/Body Program for
Infertility involved the entire team. First the technical advisor and the author would draft
an entire module using the screen-by-screen plan. Once a draft of a module was created,
Dr. Domar provided additional feedback and the technical advisor and the author would
adjust the module accordingly. Once we were satisfied with a module, we asked our
group of research associates to test each of the modules. The research associates would
go through each of the modules as if they were participants and provide feedback about
content, flow, and technical difficulties. Based on the comments of the research
associates, the technical advisor and the author would go back through the modules and
make the appropriate modifications. Dr. Domar ultimately gave final approval for all
modules of the internet-based intervention.
In order to further test the program, the first two participants were asked to
complete the program prior to recruiting any additional participants. Any suggestions or
comments made by these participants about the program were taken into account and
several small changes were made to improve the quality of the program (i.e., improving
audio quality of a relaxation response exercise). The author asked the remaining
participants randomized to the intervention group to provide feedback about each module
and the program overall, comments received through the remainder of the study were not
used to modify the program.
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Data Analytic Strategy
Sample size considerations. The sample size for this study was set at a minimum of
30 participants, half of which were to be randomized into the intervention group. The
sample size minimum was determined based on feasibility and recommendations for pilot
studies preceding clinical trials (Rounsaville, Carroll, & Onken, 2001). Other studies with
a design similar to the proposed study have had similar sample sizes (Ramel, Goldin,
Carmona, & McQuaid, 2004; Roemer, Orsillo, & Salters-Pedneault, 2008; Titov et al.,
2011). In terms of drop outs, one similar study that recruited infertile individuals for an
internet-based intervention reported drop-out rates of 18% for the intervention group and
14% for the control group (Haemmerli et al., 2010). Another study involving infertile
women reported drop-out rates (defined as lack of compliance) as 62% for the
intervention group and 42% for the control group (Van Dongen et al., 2016). Based on
this, it was expected that at least 48% of participants would be retained. In order to assure
that we recruited the minimum number of participants to reach the target goal of at least
30 retained and adhered participants for the analyses, 71 participants were recruited and
randomized (36 = intervention; 35 = wait-list).
Preliminary Analyses: Whole Sample Descriptives First, the participant flow
through stages of the RCT are presented. Second, preliminary analyses consisted of
descriptive statistics of all study variables. Specifically, study variables, including
demographics (i.e., age, education, family income, ethnicity, etc.), recruitment (i.e., state
of residence, description of residence, etc.), reproductive (i.e., months trying to conceive,
infertility diagnosis, etc.), psychological (i.e., psychiatric diagnosis, medication, etc.), and
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expectations for intervention (i.e., CEQ) characteristics of the whole sample are
presented. Third, to explore the transdiagnostic characteristics of the sample, the
relationship between BAI and BDI scores at pre-assessment was analyzed using
Pearson’s correlations.
Preliminary Analyses: Pre-Assessment Group Differences. The intervention
and wait-list groups were compared at pre-assessment on demographic and primary
study outcome variables (BAI, BDI, FFMQ) to determine initial group differences. Group
(i.e., intervention and wait-list) differences were assessed using analysis of variance (i.e.,
ANOVA) and Pearson’s chi-square analyses conducted in IBM SPSS Statistics for
Windows, version 23 (SPSS 23; IBM Corp., Armonk, N.Y., USA). If differences
emerged, they were controlled in the primary analyses.
Primary Analyses: Acceptance to engage in internet-based treatment
(Hypothesis 1). Simple descriptive statistics are presented to assess acceptance to
engage in intervention, measured by the following: (1) retention rates, (2) adherence to
intervention, and (3) satisfaction with intervention. Retention was defined initially as
completing the post-assessment, but (as will be explained) was modified to completing
the mid-assessment. Additionally, adherence was defined as participants in the
intervention group who completed five or more modules of the internet-based Mind/Body
Program for Fertility. Satisfaction with intervention was assessed after each module by
asking how (1) easy and (2) helpful each module was.
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Primary Analyses: Outcomes (Hypotheses 2-4). Mplus 7.31 software (Muthén
& Muthén, 2010) was used to conduct path analysis to assess the effect of intervention
(versus wait-list) on the three outcome variables (i.e., BAI, BDI, and FFMQ) after
accounting for baseline levels and time in months between pre and mid-point assessments
(see Figure 1 for the model tested). Effect sizes were calculated using Cohen’s d (Cohen,
1988). All participants who were randomized are included in the analyses. Missingness
was assessed through a missing values analysis conducted in SPSS 23 to determine if
maximum likelihood estimation techniques would be appropriate for the outcome
analyses. If missingness was determined to be missing completely at random, maximum
likelihood estimation with robust standard errors (MLR) was used to account for missing
data in the regression analyses.
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Figure 1. Path model for primary hypotheses
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Secondary Analyses. As the BAI was the primary outcome measure, secondary
analyses were conducted with a group of participants with elevated BAI scores (10 and
above, i.e., mild anxiety; Beck et al., 1999). Examination of an elevated anxiety symptom
group specifically is consistent with the only other internet-based study for women with
infertility where anxiety and depression symptoms were assessed separately (Haemmerli
et al., 2010). Initial analyses consisted of descriptive statistics of all study variables (i.e.,
demographic, recruitment, reproductive, and psychological characteristics), including the
main outcome variable (i.e., BAI). The path analysis performed in MPlus 7.31 software
(Muthén & Muthén, 2010) on the BAI of the whole sample was repeated with the
elevated group.
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RESULTS

Preliminary Analyses
Descriptives: Whole Sample. A descriptive analysis of each step of participant
progress separated by group (i.e., intervention and wait-list) is delineated in a CONSORT
Flow Diagram (see Figure 2). Fifty-two percent of participants who consented to
participate (81 of 155) completed the initial screener and 6% (n = 5) of these participants
did not meet the study criteria. Of the participants who did not complete the entire initial
screener, 28% expressed interest, but did not initiate the screener, 23% did not complete
the initial screener (and were not sent the MINI as a result), 32% did not complete the
MINI, 8% did not meet criteria for primary infertility, 4% had completed a Mind/Body
Program and were regularly practicing relaxation techniques (i.e., 200+ minutes a week),
and 4% indicated that they were not interested in continuing with the study and/or the
internet-based Mind/Body Program for Fertility (and were not sent the MINI as a result).
Individuals who appeared to meet inclusion criteria for the study, but did not complete
the MINI, were not invited to complete the pre-assessment as it was unclear if they met
any of the remaining exclusion criteria (i.e., substance abuse/dependence disorder).
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Figure 2. CONSORT flow diagram whole sample
160 invitations to
participate in
screening were sent

84
(5 did not consent; 5
did not meet criteria; 74
did not initiate or
complete all of the
screener)

76 eligible agreed to
participate

71 completed preassessment &
enrolled

2 did not
complete 5week
assessment; 1
BAI only

6 did not
complete post
assessment

5
(4 did not complete preassessment; 1 not
randomized)

35
randomized to
wait-list group

36 randomized
to treatment
group

33 completed
5-week
assessment

27 completed
5-week
assessment

27 completed
postassessment

3 completed
postassessment

35 analyzed

36 analyzed
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9
(2 became
pregnant, 3
due to time
constraints; 5
unknown; 1
BAI only)

23 did not
complete
postassessment

A total of 71 participants consented to the study, completed both the screener and
pre-intervention assessment, enrolled in the study, and were randomized to either the
intervention or wait-list group. The demographic characteristics of the sample reported
during the screener are delineated in Table 3. Of particular note, two-thirds of the sample
had a graduate degree, one-third had an income greater than $140,000, four-fifths were
Caucasian/white, and four-fifths worked full-time. Although none of the individuals in
the study had their own biological children (based on the set inclusion criteria requiring
that participants met for primary infertility), three participants reported adopted, fostered,
or step- children.
Although the majority of participants reported residing in New York (8.5%),
overall participants were fairly evenly distributed among several states (25 states).
Interestingly, when looking at region in the United States, several participants reported
residing in the Midwest (i.e., Illinois, Indiana, Iowa, Kansa, Minnesota, Ohio, and
Wisconsin). One participant reported living in Canada and three lived in other countries.
Overall, most participants reported living in the suburbs/outskirts of town or in the
country side (see Table 4). Furthermore, most participants reported finding out about the
study through Facebook (i.e., social media website) and Resolve.org (i.e., forum/blog).
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Table 3. Whole sample demographic characteristics at screener
Variable
Age

M (Range)

SD

33.16 (27-41)

3.75

%

Marital Status
Married

94.40

Living with Partner

1.40

Separated

1.40

Single

2.80

Duration of Relationship (yrs)

8.32 (3-21)

Partners Gender*
Male

90.10

Female

2.80

Male to Female

2.80

Number of Children*

0.07 (0-2)

0.35

Education
Completed grade school

1.40

Completed high school

1.40

Some college

1.40

Completed college

25.40

Some graduate school

4.20

A graduate degree

66.20

Family Income
Less than $30,000

1.40

$30,000-$49,999

4.20

$50,000-$69,999

11.30

$70,000-$89,999

15.50

$90,000-109,999

21.10

$110,000-$139,999

9.90

Greater than $140,000

31.00
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Table 3 (cont’d)
Race/Ethnicity
African-American/Black

5.60

Asian

4.20

Caucasian/White

80.30

Hispanic

2.80

More than one ethnic group

5.60

Not known

1.40

Employment
Homemaker

7.00

Part-Time

9.90

Full-Time

83.10
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Table 4. Whole sample demographic characteristics at screener
Variable

%

State Currently Living
Arizona

1.40

California

5.60

Colorado

2.80

Georgia

2.80

Illinois

4.20

Indiana

1.40

Iowa

1.40

Kansas

1.40

Louisiana

1.40

Maine

4.20

Massachusetts

5.60

Michigan

2.80

Minnesota

2.80

New Hampshire

4.20

New York

8.50

North Carolina

5.60

Ohio

1.40

Oregon

1.40

Pennsylvania

2.80

South Carolina

1.40

Texas

2.80

Virginia

5.60

Vermont

5.60

Washington

8.50

Wisconsin

1.40

Outside the United States

5.60

Best Description of Living Area
Rural/Country/Countryside

22.50

Suburbs/suburbia/outskirts of town

54.90

Downtown in a small or medium-sized city

11.30

Downtown in a large city

11.30
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Table 4 (cont’d)
Recruitment Source
Facebook

16.90

Fertility Clinic/Center

12.70

Friend

2.80

Forum/Blog

26.80

Reproductive Specialist

5.60

Mturk

7.00

Study Flyer

4.20

Website

12.70

Podcast

5.60

Psychologist/Counselor

1.40

80

All randomized participants identified as meeting the definition for infertility and
no participants had given birth to a child. There was a large range in the time participants
reported trying to conceive, ranging from one year to nearly 14 years. The majority of
participants had reported being diagnosed with “female-factor” or “unexplained”
infertility. Over half of the sample reported that their insurance covered at least some if
not all of their fertility treatment. Nearly a quarter of participants (n = 18) reported having
experienced at least one miscarriage, with 11% (n = 8) reporting several miscarriages (see
Table 5 for more information on reproductive characteristics).
Eighty-four percent of participants did not meet criteria for a psychiatric diagnosis
as assessed by the MINI (see Table 6). The majority of participants that met criteria for a
psychiatric diagnosis met for Major Depressive Disorder. Nearly 17% of participants
reported taking psychiatric medication(s), including SSRI’s (i.e., Zoloft, Fluoxetine),
MAOI’s (i.e., Bupropion), benzodiazepines, and medication for ADHD. Twenty-six
(38%) participants reported seeing a counselor or therapist. Of these participants, 65%
reported seeing a therapist to help them cope with reproductive-distress (i.e., infertility,
fertility treatment, and/or miscarriages). Although no participants completed a formal
Mind/Body Program, 39% of participants reported engaging in at least seventy minutes
of some type of relaxation exercise on average (i.e., yoga, breath-focus, mindfulness,
prayer, tai-chi, etc.) per week (estimated 10 minutes a day) with the majority of
participants reporting yoga as their relaxation exercise.
Overall, on the CEQ participants reported that the internet-based Mind/Body
Program for Fertility seemed logical. Thirty-eight percent of participants indicated that
81

the program seemed “very logical,” with all participant scores being above 5 “somewhat
logical” (possible range from 1-10). The majority of participants (94.4%) indicated that
they thought that the intervention would be at least “somewhat useful” in reducing their
anxiety/depressive symptoms, with 16.9% of participants indicating it would be “very
useful.” Additionally, the majority (88.4%) of participants reported that they were at least
“somewhat confident” that they would recommend this treatment to a friend experiencing
similar problems, with 26.8% indicating they were “very confident.” Eighty percent of
participants reported that they expected at least a 50% improvement in their anxiety
and/or depressive symptoms by the end of the program (see Table 7 and 12).
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Table 5. Whole sample reproductive characteristics at screener
Variable
Months Trying to Conceive

M (Range)

SD

31.59 (11-164)

21.59

%

Infertility Diagnosis
Male-Factor

9.90

Female-Factor

32.40

Combined (Female/Male Factor)

19.70

Unexplained

36.60

Unknown

1.40

Current Stage of Fertility Treatment
None

4.20

Diagnostic Testing

15.50

Medication/Injections

8.50

Intrauterine Insemination

21.10

Waiting to start IVF

23.90

Started IVF

26.80

Insurance Coverage for Treatment
None

36.60

Some

35.20

All

23.90

Not known/No Insurance

4.20

Miscarriages

0.47 (0-6)
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1.03

Table 6. Whole sample psychological characteristics at screener
Variable

M (Range)

SD

%

Psychiatric Diagnosis
None

84.50

Major Depressive Disorder

5.60

Panic Disorder w/ Agoraphobia

1.40

Agoraphobia

4.20

Anorexia Nervosa

1.40

Generalized Anxiety Disorder

1.40

Multiple Disorders

1.40

Psychiatric Medication

16.90

Currently in Therapy/Counseling

38.00

Minutes of Relaxation Techniques

82.61 (0-480)

89.86

Notes: One participant met criteria for Agoraphobia, Social Anxiety Disorder,
and Generalized Anxiety Disorder. Relaxation techniques were measured by
minutes per week.
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Table 7. Credibility/Expectancy for Improvement Scale for the whole sample at pre-assessment
M (Range)
SD
Credibility Scale
How logical does the therapy offered to you seem (1-9)
7.87 (5.00-9.00)
1.19
How successfully do you think this treatment will be in
6.90 (2.00-9.00)
1.66
reducing your symptoms (1-9)
How confident would you be in recommending this treatment
6.88 (2.00-9.00)
1.89
to a friend (1-9)
Composite Score
0.11 (-7.65-3.31)
2.51
Expectancy Scale
How much improvement in your symptoms do you think will
occur (0-100%)
How much do you really feel that therapy will help you to
reduce your symptoms (1-9)
How much improvement in your symptoms do you really feel
will occur (0%-100%)
Composite Score

61% (10%-100%)

21%

6.94 (2.00-9.00)

1.7

58% (10%-100%)

22%

0.01 (-7.25-4.80)

2.63

Note: The items below each scale are the individual items related to each scale. The composite
scores were made up by standardizing each of the items within the scale and then summing the
three items for each scale.
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Extant literature has established clinical definitions of minimal (0-7), mild (8-15),
moderate (16-25), and severe (26-63) anxiety symptom severity for the BAI (e.g., Beck et
al., 1993). At the pre-assessment, 46.5% of participants had scores in the minimal anxiety
symptom severity range, 36.6% in the mild range, 11.3% in the moderate range, and
5.6% in the severe range. Although the pre-assessment was typically completed within
nine days of the screener, anxiety symptom severity scores decreased slightly from the
initial screener to the pre-assessment (see Table 13 for descriptives on outcome
variables).
Similar to the BAI, the BDI has established clinical definitions for minimal (013), mild (14-19), moderate (20-28), and severe (29-63) depression symptom severity
(Beck, Steer, Brown, 1996). When asked about depression symptoms during the preassessment, 50.7% of participants met for minimal depression symptom severity, 16.9%
met for mild, 18.3% met for moderate, and 14.1% for severe.
The average FFMQ-Total score for the overall sample was 122.06 (SD = 19.40) at
the pre-intervention assessment. The FFMQ-Total mean scores observed in this sample
are similar to mean scores reported for other “non-meditating” samples (e.g., van Dam et
al., 2009; de Bruin et al., 2012).
When examining the relationship between pre-assessment anxiety and depression
symptom severity for the sample overall, a significant correlation was found, r(71) =
0.46, p < 0.001. Thirty-eight percent of participants met for both minimal anxiety and
depression symptom severity, 12.7% met for elevated anxiety only (i.e., BAI = 10+),
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16.9% met for elevated depression only (i.e., BDI = 14+) and 32.4% met for elevated
anxiety and depression.
Pre-Assessment Group Differences. Tables 8 through 12 present preassessment group means or percentages in each group for demographics variables,
recruitment characteristics, reproductive characteristics, and psychological
characteristics, respectively. No group (i.e., intervention vs. wait-list) differences
emerged when examined by ANOVA or Pearson’s chi-square analyses. The preassessment means for BAI, BDI, and FFMQ are presented in Table 13. There were no
group differences when examined by ANOVA at the screener (BAI-only) or preassessment for the outcome variables.
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Table 8. Whole sample demographic characteristics at screener separated by group
Intervention
Wait-List
M
Variable
(Range)
SD
%
M (Range)
SD
Age

32.83
(27-41)

33.49
(27-41)

3.56

%

3.97

Marital Status
Married

91.70

97.10

Living with Partner

2.80

0.00

Separated

2.80

0.00

2.80

2.90

Single
Duration of Relationship
(yrs)

8.62
(3-21)

8.03
(3-17)

4.07

3.83

Partners Gender*
Male

94.10

94.10

Female

2.90

2.90

Male to Female
Number of Children*

2.90
0.08
(0-2)

0.37

2.90
0.06
(0-2)

0.34

Education
Completed grade school

0.00

2.90

Completed high school

2.80

0.00

Some college

0.00

2.90

Completed college

25.00

25.70

Some graduate school

5.60

2.90

A graduate degree

66.70

65.70

Less than $30,000

2.90

0.00

$30,000-$49,999

5.90

3.00

$50,000-$69,999

8.80

15.20

$70,000-$89,999

17.60

15.20

$90,000-109,999

14.70

30.30

$110,000-$139,999

14.70

6.10

Greater than $140,000

35.30

30.30

Family Income

88

Table 8. (cont’d)
Race/Ethnicity
African-American/Black

5.60

5.70

Asian

0.00

8.60

Caucasian/White

83.30

77.10

Hispanic

5.60

0.00

More than one ethnic group

2.80

8.60

Not known

2.80

0.00

Homemaker

11.10

2.90

Part-Time

2.80

17.10

Full-Time

86.10

80.00

Employment
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Table 9. Whole sample recruitment characteristics at screener separated by group
WaitIntervention
List
Variable

%

%

Arizona

0.00

2.90

California

3.10

8.60

Colorado

6.30

2.90

Georgia

12.50

2.90

Illinois

8.30

0.00

Indiana

2.80

0.00

Iowa

2.80

0.00

Kansas

2.80

0.00

Louisiana

2.80

0.00

Maine

0.00

8.60

Massachusetts

5.60

8.60

Michigan

5.60

0.00

Minnesota

0.00

5.70

New Hampshire

5.60

2.90

New York

13.90

2.90

North Carolina

5.60

5.70

Ohio

0.00

2.90

Oregon

0.00

2.90

Pennsylvania

2.80

2.90

South Carolina

0.00

2.90

Texas

0.00

5.70

Virginia

11.10

0.00

Vermont

0.00

11.40

Washington

5.60

11.40

Wisconsin

2.80

0.00

Outside the United States

2.80

8.60

Rural/Country/Countryside

19.40

25.70

Suburbs/suburbia/outskirts of town

61.10

48.60

Downtown in a small or medium-sized city

8.30

14.30

Downtown in a large city

11.10

11.40

State Currently Living

Best Description of Living Area
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Table 9. (cont’d)
Recruitment Source
Facebook

13.90

20.00

Fertility Clinic/Center

8.30

17.10

Friend

2.80

2.90

Forum/Blog

30.60

22.90

Reproductive Specialist

2.80

8.60

Mturk

11.10

2.90

Study Flyer

5.60

2.90

Website

13.90

11.40

Podcast

2.80

8.60

Psychologist/Counselor

0.00

2.90
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Table 10. Whole sample reproductive characteristics at screener separated by group
Intervention
Wait-List
M
Variable
(Range)
SD
%
M (Range)
SD
34.47
28.53
Months Trying to Conceive
(11-164) 26.52
(12-66)
13.28

%

Infertility Diagnosis
Male-Factor

8.30

11.40

36.10

28.60

19.40

20.00

33.30

40.00

2.80

0.00

None

5.60

2.90

Diagnostic Testing

8.30

22.90

Medication/Injections

2.80

14.30

Intrauterine Insemination

27.80

14.30

Waiting to start IVF

25.00

22.90

Started IVF

30.60

22.90

None

30.60

42.90

Some

38.90

31.40

All

25.00

22.90

Not known/No Insurance

5.60

2.90

Female-Factor
Combined (Female/Male
Factor)
Unexplained
Unknown
Current Stage of Fertility
Treatment

Insurance Coverage for Treatment

Miscarriages

.47 (0-3)

0.91
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0.45 (0-6)

1.15

Table 11. Whole sample psychological characteristics at screener separated by group
Intervention
Wait-List
M
Variable
M (Range)
SD
%
(Range)
SD

%

Psychiatric Diagnosis
None

77.80

91.40

8.30

2.90

2.80

0.00

Agoraphobia

2.80

5.70

Anorexia Nervosa

2.80

0.00

Generalized Anxiety Disorder

2.80

0.00

Multiple Disorders

2.80

0.00

Psychiatric Medication

13.90

20.00

Currently in Therapy/Counseling

41.70

34.30

Major Depressive Disorder
Panic Disorder w/
Agoraphobia

Relaxation Techniques

73.19
(0-255)

65.23

92.29
(0-480)

109.79

Notes: One participant met criteria for Agoraphobia, Social Anxiety Disorder, and Generalized
Anxiety Disorder. Relaxation techniques were measured by minutes per week.
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Table 12. Credibility/Expectancy for Improvement Scale for the whole sample at pre-assessment
separated by group
Intervention
Wait-List
M (Range)
Credibility Scale
How logical does the therapy offered to you
seem (1-9)
How successfully do you think this treatment
will be in reducing your symptoms (1-9)
How confident would you be in recommending
this treatment to a friend (1-9)
Composite Score
Expectancy Scale
How much improvement in your symptoms do
you think will occur (0-100%)
How much do you really feel that therapy will
help you to reduce your symptoms (1-9)
How much improvement in your symptoms do
you really feel will occur (0%-100%)
Composite Score

8.03
(5.00-9.00)
7.11
(2.00-9.00)
7.00
(3.00-9.00)
0.47
(-7.12-3.31)
66%
(20%-90%)
6.97
(3.00-9.00)
62%
(20%-100%)
0.39
(-5.35-4.80)

SD

1.13
1.64
1.81
2.34

20%
1.58
21%
2.42

M (Range)
7.71
(5.00-9.00)
6.69
(2.00-9.00)
6.77
(2.00-9.00)
-0.24
(-7.65-3.31)
56.6%
(10%-90%)
6.91
(2.00-9.00)
55%
(10%-90%)
-0.37
(-7.25-3.44)

SD

1.25
1.68
1.99
2.62

22%
1.84
24%
2.82

Note: The items below each scale are the individual items related to each scale. The composite
scores were made up by standardizing each of the items within the scale and then summing the three
items for each scale.
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Table 13. Means and standard deviations of study outcomes by time point for the whole
sample separated by group
Intervention
Wait-List
Outcome
Variable
BAI
BDI
FFMQ-T

Screener

Pre-

Mid-

Screener

Pre-

Mid-

M (SD)
10.94
(8.31)

M (SD)
9.89
(7.68)

M (SD)
9.60
(10.19)

M (SD)
12.17
(10.59)

M (SD)
10.94
(7.50)

M (SD)
12.06
(9.00)

-

14.86
(9.42)

12.38
(7.13)

-

16.68
(9.93)

18.22
(11.58)

-

125.94
(17.49)

127.73
(17.83)

-

118.07
(20.68)

120.14
(20.49)

Note: BAI = Beck's Anxiety Inventory; BDI = Beck's Depression Inventory; FFMQ-T =
Five-Factor Mindfulness Questionnaire Total Score; Pre = Pre-assessment; Mid = Mid
assessment given at 5-weeks.
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Primary Analyses
Hypothesis 1: Acceptance to engage in internet-based treatment. Although
77% of participants in the wait-list group completed the post-assessment, only 8% of
participants in the intervention group had completed the post-assessment by the close of
the study (see Figure 2). The average for the two groups was 42%, approximately the
48% proposed. However, since so few participants in the intervention group completed
the post-assessment, only mid-assessment data were used for all analyses.
At the mid-assessment, the retention rates for the intervention and wait-list group
were 75% and 94%, respectively. The percentage of participants who completed the midassessment was significantly different between the intervention and wait-list group, 2 (1,
N = 71) = 9.49, p = .002. When using the mid-assessment data, retention rates were
higher in both groups than the minimum 48% proposed.
By the close of the study, 56% (n =20) of participants in the intervention group
completed five or more modules. Specifically, 25% had only completed module one, 6%
completed the first two modules, 11% completed four modules, 3% completed five
modules, 14% completed six modules, 22% completed seven modules, 6% eight
modules, and 8% all 10 modules. When examining module completion by the end of the
study, adherence rates were higher than the minimum 48% proposed. Of note, only three
participants had completed module five by the time they completed the mid-assessment.
Therefore, most mid-assessment data presented for the intervention group were based on
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the completion of four or less modules (see Table 14). Only data collected from between
the pre-assessment and mid-assessment were used for analyses and presented.
Participants in the intervention group completed the ongoing assessments built
into each module and reported that on average the modules were moderately challenging
and helpful (see Table 14). Ninety-eight percent of participants reported that the program
was at least slightly helpful and at least 80% reported that the program was moderately to
very helpful. Helpfulness rates, which can be thought of as satisfaction, were higher than
the 70% proposed. Average homework completion was similar to number of modules
completed and partners rarely joined in completing the modules (see Table 14).
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Table 14. Mind/Body Program module data intervention group for the whole sample
Intervention
Module Data

M (SD)

Range

Module Completed by Mid (1-5)

2.39 (1.34)

0.00-5.00

Average Ease of Module (0-2)

1.46 (0.39)

0.80-2.00

Module Helpfulness (0-3)

2.18 (0.73)

0.25-3.00

Average Homework Completion (0-4)

2.27 (0.89)

0.00-4.00

Average Number of Modules Partners Joined

0.46 (1.04)

0.25-3.00
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Hypothesis 2-4: Missing Data and Covariates. Missing data for all outcome
variables were less than 18%. Additionally, the Little’s MCAR test was not significant,
2 (1, N = 58) = 3.02, p > .05; therefore, the mechanisms of missingness was treated as
missing completely at random and full information maximum likelihood estimation
techniques were used for all available data. Since the time between the pre- and midassessments was significantly different F(2, 71) = 15.94, p < .001 between the
intervention (M = 58.63; SD = 13.24) and wait-list (M = 45.42; SD = 12.33) groups, time
between the pre- and mid-assessment, as measured in days, was included as a covariate in
all models.
Hypothesis 2: Decrease in anxiety symptom severity. The main effect of the
intervention (versus wait-list) condition on mid-assessment anxiety symptom severity
(i.e., BAI) scores, after accounting for pre-assessment BAI and time between
assessments, was not significant (see Table 13 for means and Table 15 for path
coefficients). It should be noted that at mid-assessment, the overall mean BAI for the
intervention group had decreased as compared to the pre-assessment mean scores
whereas the overall mean for the wait-list group at mid-assessment had increased (see
Table 13).
Hypothesis 3: Decrease in depressive symptoms In regards to depressive
symptom severity (i.e., BDI) scores, the main effect of condition on mid-assessment
scores, after accounting for pre-assessment levels and time between assessments, was
significant (see Table 13 for means and Table 15 path coefficients). Specifically, BDI
scores decreased from pre- to mid-assessment for the intervention group and increased
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for the wait-list group. As predicted, the effect size for this analysis (d = 0.61) has been
defined as a “medium” effect (d = 0.5; Cohen, 1988), favoring the intervention group.
Hypothesis 4: Increase in mindfulness. After accounting for pre-assessment
mindfulness (i.e., FFMQ-Total) scores and time between assessments, the main effect of
the intervention condition on the mid-assessment mindfulness scores was not significant
(see Table 13 for means and Table 15 for path coefficients). 1

1

Secondary analyses were conducted on the five subscales of the FFMQ and no main effects of
intervention condition emerged.
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Table 15. Path analyses conducted using Mplus with maximum likelihood estimation with robust standard
errors for three outcomes at mid-assessment for whole sample.
Whole Sample
b

SE B

β

95% CI

p

BAI Pre

0.81

0.13

0.64

0.60 - 1.20

0.00

TimeAsse

-0.05

0.07

-0.08

-0.17 - 0.06

0.44

Condition

-2.11

2.27

-0.11

-5.85 - 1.62

0.35

0.45

0.10

BDI Pre

0.68

0.10

0.65

0.53 - .84

0.00

TimeAsse

-0.03

0.06

-0.04

-0.13 - 0.08

0.69

Condition

-4.98

1.83

-0.25

-8.00 - - 1.97

0.01

R2

0.53

0.08

FFMQ-T Pre

0.84

0.08

0.80

0.71 - 0.97

0.00

TimeAsse

0.08

0.13

0.05

-0.14 - 0.29

0.56

Condition

2.31

3.90

0.06

-4.11 - 8.73

0.55

0.68

0.06

BAI Mid

2

R

0.00

BDI Mid

0.00

FFMQ-T Mid

2

R

0.00

Note: BAI = Beck's Anxiety Inventory; TimeAsse = Time between pre- and mid- assessment; BDI =
Beck's Depression Inventory; FFMQ-T = Five-Factor Mindfulness Questionnaire Total Score; Pre =
pre-assessment; Mid = mid-assessment given at 5-weeks. SE = Standard Error.
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Secondary Analyses
Descriptives. A total of 24 participants had BAI scores of 10 or above at both the
screener and pre-assessment (n = 12 in intervention group and n = 12 in wait-list group),
enrolled in the study, and were randomized to either the intervention or wait-list group. A
CONSORT Flow Diagram for the elevated sample separated by group (i.e., intervention
and wait-list) is provided in Figure 3. Descriptive statistics for the elevated sample are
provided for all study characteristics (Table 16-19) and the outcome variable (Table 20)
separated by group (i.e., intervention and wait-list group).
At the pre-assessment, 54.2% of participants had scores in the mild anxiety
symptom severity range, 29.2% in the moderate range, and 16.7% in the severe range.
The elevated sample took on average 14 days from the screener to complete the preintervention assessment, which was five days longer than the overall sample. Similar to
the overall sample, the pre-assessment BAI scores were lower than the initial screener
scores (see Table 20).
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Figure 3. CONSORT flow diagram elevated sample
160 invitations to
participate in
screening were sent

84
(5 did not consent; 5
did not meet criteria; 74
did not initiate or
complete all of the
screener)

76 eligible agreed to
participate

71 completed preassessment & enrolled
(24 had BAI of 10+)

1 did not
complete 5week
assessment

12 BAI 10+
randomized to waitlist group

12 BAI 10+
randomized to
treatment group

11 BAI 10+
completed 5-week
assessment

1 did not
complete post
assessment

5
(4 did not complete preassessment; 1 not
randomized)

10 BAI 10+
completed 5-week
assessment

10 BAI 10+
completed postassessment

1 BAI 10+
completed postassessment

12 analyzed

12 analyzed
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2 did not
complete 5week
assessment

9 did not
complete
postassessment

Table 16. Elevated group (BAI 10+) demographic characteristics at screener separated by group
Intervention
Wait-List
M
M
Variable
(Range)
SD
%
(Range)
SD
%
Age

33.42
(28-41)

4.52

31.67
(28-37)

3.31

9.36
(3-21)

5.57

9.50
(3-15)

3.9

Marital Status
Married
Living with Partner
Separated
Single
Duration of Relationship
(yrs)
Partners Gender*
Male

100.00

100.00

Female

0.00

0.00

Male to Female

0.00

0.00

Number of Children*

0 (0)

0

0 (0)

0

Education
Completed grade school

0.00

8.30

Completed high school

8.30

0.00

Some college

0.00

0.00

Completed college

25.00

25.00

Some graduate school

8.30

8.30

A graduate degree

58.30

58.30

Less than $30,000

8.30

0.00

$30,000-$49,999

0.00

0.00

$50,000-$69,999

8.30

25.00

$70,000-$89,999

16.70

25.00

$90,000-109,999

8.30

25.00

$110,000-$139,999

16.70

8.30

Greater than $140,000

33.30

16.70

Family Income
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Table 16 (cont’d)
Race/Ethnicity
African-American/Black

0.00

0.00

Asian

0.00

8.30

100.00

83.30

Hispanic

0.00

0.00

More than one ethnic group

0.00

8.30

Not known

0.00

0.00

Homemaker

25.00

8.30

Part-Time

8.30

8.30

Full-Time

66.70

83.30

Caucasian/White

Employment
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Table 17. Elevated group (BAI 10+) recruitment characteristics at screener separated by group
Intervention
Wait-List
Variable

%

%

Arizona

0.00

0.00

California

0.00

8.30

Colorado

0.00

8.30

Georgia

0.00

0.00

Illinois

0.00

0.00

Indiana

8.30

0.00

Iowa

8.30

0.00

Kansas

0.00

0.00

Louisiana

8.30

0.00

Maine

0.00

25.00

Massachusetts

0.00

8.30

Michigan

8.30

0.00

Minnesota

0.00

0.00

New Hampshire

8.30

0.00

New York

16.70

0.00

North Carolina

8.30

8.30

Ohio

0.00

0.00

Oregon

0.00

0.00

Pennsylvania

8.30

0.00

South Carolina

0.00

0.00

Texas

0.00

0.00

Virginia

8.30

0.00

Vermont

0.00

16.70

Washington

0.00

0.00

Wisconsin

8.30

0.00

Outside the United States

0.00

8.30

Rural/Country/Countryside

16.70

33.30

Suburbs/suburbia/outskirts of town

66.70

41.70

Downtown in a small or medium-sized city

0.00

25.00

Downtown in a large city

16.70

0.00

State Currently Living

Best Description of Living Area
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Table 17 (cont’d)
Recruitment Source
Facebook

8.30

16.70

Fertility Clinic/Center

8.30

25.00

Friend

8.30

0.00

Forum/Blog

25.00

0.00

Reproductive Specialist

0.00

8.30

Mturk

16.70

0.00

Study Flyer

0.00

8.30

Website

25.00

25.00

Podcast

0.00

16.70

Psychologist/Counselor

0.00

0.00
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Table 18. Elevated group (BAI 10+) reproductive characteristics at screener separated by group
Intervention
Wait-List
Variable
Months Trying to Conceive

M (Range)
44.91
(11-164)

SD

%

42.68

M (Range)
29.25
(15-48)

SD

%

9.86

Infertility Diagnosis
Male-Factor

8.30

25.00

Female-Factor

25.00

25.00

Combined (Female/Male Factor)

25.00

16.70

Unexplained

33.30

33.30

8.30

0.00

None

16.70

0.00

Diagnostic Testing

0.00

16.70

Medication/Injections

0.00

8.30

Intrauterine Insemination

41.70

33.30

Waiting to start IVF

16.70

33.30

Started IVF

25.00

8.30

None

25.00

50.00

Some

58.30

33.30

All

8.30

16.70

Not known/No Insurance

8.30

0.00

Unknown
Current Stage of Fertility
Treatment

Insurance Coverage for Treatment

Miscarriages

0.83 (0-3)

1.12
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0.17 (0-2)

0.58

Table 19. Elevated group (BAI 10+) psychological characteristics at screener separated by group
Intervention
Wait-List
M
M
Variable
(Range)
SD
%
(Range)
SD
%
Psychiatric Diagnosis
None

50.00

83.30

16.70

8.30

8.30

0.00

Agoraphobia

8.30

8.30

Anorexia Nervosa

0.00

0.00

Generalized Anxiety Disorder

8.30

0.00

Multiple Disorders

8.30

0.00

16.70

16.70

Major Depressive Disorder
Panic Disorder w/
Agoraphobia

Psychiatric Medication
Currently in Therapy/Counseling
Minutes of Relaxation
Techniques

58.30
69.17
(5-165)

53.21

58.30
97.5
(5-370)

108.91

Notes: One participant met criteria for Agoraphobia, Social Anxiety Disorder, and Generalized
Anxiety Disorder. Relaxation techniques were measured by minutes per week.
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Table 20. Means and standard deviations of BAI by time point and group for elevated group (BAI 10+)
Intervention
Wait-List
Screener
Outcome
Variable
BAI

M (SD)
19.33
(7.95)

Pre-

Mid-

Screener

Pre-

Mid-

M (SD)
16.17
(8.49)

M (SD)
10.60
(10.16)

M (SD)
22.67
(.97)

M (SD)
19.17
(6.78)

M (SD)
20.91
(9.01)

Note: BAI = Beck's Anxiety Inventory; Pre = Pre-assessment; Mid = Mid assessment given at 5weeks.
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Decrease in anxiety symptom severity for elevated group. Since the time
between the pre- and mid-intervention assessment was significantly different F(2, 21) =
8.10, p = 0.01 for the elevated sample between the intervention (M = 54.40; SD = 6.19)
and wait-list (M = 44.09; SD = 9.80) groups, time was included as a covariate. The main
effect of condition on mid-intervention anxiety symptoms in the elevated sample, after
accounting for pre-intervention anxiety levels and time between assessments, was
significant (see Table 20 for means and 21 for path coefficients). Anxiety symptom
severity scores decreased from pre- to mid- assessment for the intervention group and
increased for the wait-list group. The effect size for this analysis (d = 1.07) was found to
exceed what has been defined as a “large” effect (d = 0.8; Cohen, 1988), favoring the
intervention group.
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Table 21. Path analysis conducted using Mplus with maximum likelihood estimation with robust standard
errors for BAI scores at mid-assessment for elevated group (BAI 10+)
Elevated Group
b

SE B

β

95% CI

p

BAI Pre

0.85

0.21

0.60

0.35 - 0.85

0.00

TimeAsse

0.57

2.04

0.07

0.07 - 0.49

0.78

Condition

-9.64

4.91

-0.46

-0.45 - 0.11

0.03

0.62

0.08

BAI Mid

2

R

0.00

Note: BAI = Beck's Anxiety Inventory; TimeAsse = Time between pre- and mid- assessment; Pre =
pre-assessment; Mid = mid assessment given at 5-weeks. SE = Standard Error.
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DISCUSSION
Infertility is a frequently occurring chronic health problem among women which
is often accompanied by anxiety symptoms as well as depressive symptoms. Drawing
from the diathesis-stress model (Ingram & Luxton, 2005; Stanton & Dunkel-Schetter,
1991), the current study was based on the theoretical premise that infertility activates
anxiety vulnerabilities, which leads to the development of emotional symptoms. Drawing
from the literature on empirically supported treatments, the Mind/Body Program for
Fertility (Domar et al., 1990; Domar et al., 1992; Domar et al., 2000) was selected as the
intervention to translate into an internet-based program and evaluate. Converting an inperson intervention into an internet-based intervention and evaluating it is important to
make the intervention accessible and convenient, as well as private, for women with
infertility.
The development and evaluation of the current pilot study aimed to assess the
retention rates, intervention adherence, satisfaction, and outcomes of an internet-based
mind/body intervention designed for women experiencing infertility. It was hypothesized
that participants will be accepting of the program based on completion and adherence
rates and satisfaction ratings; a reduction in anxiety symptoms and depression symptoms
will occur; and that there would be an increase in mindfulness skills. The hypotheses
were partially supported.
To summarize the findings, using post-assessment as the criterion for completion,
few (3) intervention participants had completed this assessment at the termination of the
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study. This would indicate that the hypothesized completion rate for this group and, the
overall sample (48%) as a consequence, was not met and the adherence and outcome
(e.g., anxiety reduction) measures could not be evaluated. The completion rate at the
close of the current study for this dissertation was substantially below those reported in
prior studies (e.g., Haemmerli et al., 2010; van Dongen et al., 2016). However, when
completion, adherence, and outcomes were evaluated at mid-assessment, some of the
hypotheses were supported. Specifically, overall retention rates at this assessment were
similar (i.e., Haemmerli et al., 2010) or higher (i.e., van Dongen et al., 2016) than
retention rates seen in previous studies. Adherence rates for the intervention group were
similar to what was expected and what has been seen in similar studies (van Dongen et
al., 2016). Additionally, satisfaction rates for the current study at mid-assessment were
higher than what has been reported for previous internet-based interventions that
addressed anxiety and/or depression in both the general population (Andrews et al., 2010)
and women experiencing infertility (van Dongen et al., 2016).
In terms of outcomes, relative to the wait-list group, the intervention group
decreased in depression symptom severity from the pre-intervention assessment to the
mid-intervention assessment. Similar findings emerged for anxiety symptom severity
when examining the elevated group (i.e., BAI 10+). For both depression and anxiety
symptom severity, the wait-list group increased in severity from the pre-assessment to the
mid-assessment. The finding in the wait-list group is consistent with previous research
indicating that distress for women with infertility increases over time (e.g., Berg &
Wilson, 1991) whereas individuals engaged in therapeutic interventions have shown
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improvement (e.g., Domar et al., 2000; Hammerli et al., 2009). In contrast, there was no
differential effects across assessments (pre- and mid-) for the two groups (intervention
and wait-list) on the mindfulness measure with either the whole sample or the elevated
sample. This finding is not surprising as mindfulness was not formally introduced until
session four and few participants (67%) completed four or more sessions by the midassessment.
These findings suggest that a 10 module intervention which is internet-based may
be too long for women experiencing infertility to complete in a timely manner and may
not be necessary to achieve reductions in anxiety and depression symptoms. The latter
conclusion is contrary to several recent reviews which have questioned whether there was
an adequate dosage level in some studies (e.g., Boivin, 2003; Hämmerli et al., 2009). In
the current study as few as 2.39 sessions on average was associated with reductions in
depressive symptoms and, when examining those with elevated anxiety scores at the preassessment, anxiety symptoms. This finding, as well as the finding that mindfulness did
not change, brings into question the mechanisms that led to change in depressive and
anxiety symptoms.
Several possibilities are deserving of consideration. First, mindfulness was not
formally introduced initially until session four; therefore, it is not surprising that
mindfulness scores did not change from pre- to mid-assessment. Furthermore, the
Mind/Body Program for Fertility is a combination of mindfulness and cognitive therapy.
The evidence-based cognitive-behavioral components, which were not assessed, may
have been the critical aspect of intervention leading to change and, in fact, some of these
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components were covered in the initial sessions (e.g., relaxation training, communication
strategies). Finally, individualized therapeutic feedback and psychoeducation in general
was a consistent theme in the early modules and may have been influential. Both of these
components of the intervention (i.e., individualized therapeutic feedback and
psychoeducation) have been associated with decreases in psychological symptoms (e.g.,
Donker, Griffiths, Cuijpers, & Christensen, 2009; Poston & Hanson, 2010).
An additional consideration is expectations for change with the intervention. A
recent meta-analytic review incorporating 46 studies indicated that expectations for
change had a significant, but small, effect on outcomes in psychological intervention
studies (Constantion, Arnkoff, Glass, Ametrano, & Smith, 2011). In the current study,
expectations for successful treatment were relatively high (i.e., 80% of participants
expected at least a 50% reduction in anxiety and depression symptoms). Especially when
considered in the context of the few available psychological interventions for infertilityrelated distress and the barriers to accessing these interventions, high level of
expectations of an easily accessible and private internet-based intervention may have
played a role in the change which occurred. 2
An interesting finding was that an intervention effect emerged for the total
randomized sample for depression, but not anxiety, symptoms. One explanation for this
finding is that the mean level of depressive symptoms was 50% higher at the preassessment than the mean level of anxiety symptoms (see Table 13).
2

The author tested the expectations hypothesis by conducting a post-hoc regression where expectations
were examined as a predictor of change from pre-assessment to mid-assessment for the intervention
group. The expectations beta for the BDI for the whole sample was not significant (β = -.14, p > .05). The
same analysis for the BAI for the elevated group was significant (β = -.37, p < .001). These findings
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provide some support for the expectations hypothesis.

As a consequence, scores on the anxiety measure, relative to those on the depression
measure, potentially had more of a “floor effect,” preventing the opportunity for change.
However, an intervention effect did emerge for anxiety symptoms when a smaller but
elevated group (i.e., BAI 10+) at pre-assessment was examined. For this select group, the
pre-intervention assessment anxiety symptom score was almost twice as high as for the
sample as a whole (see Tables 13 & 20), allowing more “room for change.” The
significant findings when examining a group with elevated symptoms is congruent with
the two other internet-based studies examining depressive and anxiety symptoms as
outcome (Haemmerli et al., 2010; van Dongen et al., 2016).
The current finding for anxiety in the elevated group is important as these
symptoms represented the primary outcome in this study. The finding suggests that, while
the internet-based Mind/Body Program for Fertility is effective, it is limited to those with
elevated anxiety scores. However, it is worth noting that the trend in the data with the
whole sample (an increase in anxiety in the wait-list group and a decrease in the
intervention group) suggests that, with a larger sample, a significant relationship may
well emerge. Nevertheless an important conclusion is evident from the two significant
findings: Consistent with the transdiagnostic model, thefindings from the total and
elevated group analyses indicate that both depression and anxiety symptoms are reduced
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by the internet-based mind/body intervention albeit based on different participant severity
of symptoms at the pre-assessment.
Continuing to build on the clinical implications of the findings, it is important to
place them in the context of a chronic illness. As highlighted in Clarke and Currie’s
(2009) review on the co-morbidity of chronic illness, anxiety, and depression, our current
health care model –to either treat the physical disease or the mental illness first –is not
effective, efficient, or cost-effective. This is as true for infertility as it is with any other
chronic illness. Clarke and Currie (2009) suggested that integrated care models are
needed, such as a model that includes screening and monitoring as well as
psychoeducation regarding the interaction between the disease and mental health, selfmanagement advice and cognitive-behavioral strategies. The findings of the current study
suggest that this internet-based mind/body intervention could change the way infertility
medical care is provided. For instance, infertility clinics could implement easy and quick
screening and monitoring for distressed patients and offer a convenient, effective, and
affordable intervention (e.g., internet-based) as an option for these patients, thus
providing an increase in emotional support and care.
The current study had a number of limitations. First, as has been stressed, only a
small percentage of the modules were actually received by the participants. Although
significant intervention effects emerged, it is unknown from the current study whether the
larger planned dosage would be more effective. The current findings suggest that briefer
interventions should be developed or, alternatively, incentives could be developed for
completion of the 10 modules. Second, the current study did not include any follow-up
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assessments. Long term follow-up, including pregnancies that occur, is imperative to
reach conclusions about program effectiveness. Third, the e-therapist was limited to one
individual, the author, who may have been more invested in the program than other etherapists would be. However, it should be noted that four other clinicians were involved
in drafting feedback for participants as they completed each module, potentially reducing
any concern about this limitation. Fourth, all outcomes were self-reported by the
participant. Evaluation of an internet-based program by other data (e.g., observation) is
difficult; however, at a minimum medical record data may be informative. Fifth, although
randomization resulted in the intervention and wait-list groups not differing significantly
at the pre-assessment on demographic and other variables, the two groups did differ on
days between the pre-intervention and mid-intervention assessment. This could have
influenced the outcome; however, an effort was made to control for the difference by
covarying days between assessments. Sixth, although the anxiety and depression scores at
pre-assessment were similar to prior studies (e.g., Demyttenaere et al, 1998; Peterson et
al., 2007), the rates for anxiety and depression disorders were lower than prior studies
(Klemetti et al., 2010). Thus, the sample may not be representative of women with
infertility who seek both fertility treatment and/or psychological support. Additionally, as
the sample was well educated and had a high income, it may not be representative.
Seventh, through Facebook or blogs/forums, the results may differ from studies where
women are recruited through more traditional means (e.g., reproductive facilities).
Eighth, it is also important to note that approximately one hour per module per
participant was devoted to providing feedback by the e-therapist. This amount of
therapist effort may not have resulted in a saving of time with this internet-based
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intervention. Future research should include a cost-analysis. Ninth, the enrollment criteria
were changed after the study was initiated, which could have affected the results.
Beyond the limitations, several strengths should be pointed out. First, this is only
the third study to examine an internet-based intervention for women experiencing
infertility with anxiety and/or depression symptoms serving as the outcomes. As has been
pointed out repeatedly, infertility is a major chronic illness and developing and evaluating
a self-administered low-cost (financially and time) intervention that can be administered
in the privacy of one’s own home is important. Second, what started as a pilot study
examining only effects sizes was successful at recruiting and randomizing 71 women
with important findings emerging. Third, a comprehensive assessment of the 71
participants allowed the identification of the demographic, psychological, and medical
characteristics of the current sample, which could be controlled for group differences if
necessary. Fourth, the sample was recruited nationally, representing 25 states, as well as
having some international representation. Fifth, a conservative data analytic approach
was utilized (maximum likelihood estimation with robust standard errors), which
increases confidence in the findings.
Several future research directions have been suggested, including developing and
evaluating an abbreviated internet-based program, collecting follow-up data, utilizing
multiple e-therapists, inclusion of cost-analyses, and inclusion of data beyond self-report.
An additional direction includes interaction of a psychological intervention like the
Mind/Body Program for Fertility with medical efforts for fertility treatment.
Psychological interventions, such as the Mind/Body Program for Fertility and the current
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internet-adaptation, need to be developed and evaluated, perhaps in isolation; however,
unless these programs are integrated into a comprehensive intervention package, as
espoused by Clarke and Currie (2009), fertility treatment will fall short of providing ideal
services for women.
In conclusion, the present RCT was the first to assess the potential to translate the
in-person Mind/Body Program for Fertility into an internet-based intervention and test its
acceptability and effectiveness with women experiencing infertility. Satisfaction and
intervention adherence at mid-assessment suggest feasibility and acceptability. Results at
the same assessment suggest significant depression improvements for women in general
who are experiencing infertility and anxiety improvements for women with elevated
anxiety who are experiencing infertility. Internet-based mind/body interventions in
general are a promising area for future research with women (and potentially couples)
experiencing infertility.
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